Exhibit 99.6
Free translation from original Dutch filed version for information purposes only | F-cap 1 |
ANNUAL ACCOUNTS AND OTHER DOCUMENTS TO BE FILED IN
ACCORDANCE WITH THE BELGIAN COMPANIES AND
ASSOCIATIONS CODE
IDENTIFICATION DETAILS (at the filing date)
NAME: Galapagos
Legal form 1 : Public limited company | ||||||
Address: Generaal De Wittelaan | ||||||
Postal code: 2800 | Town: Mechelen | N°. L11 , box A3 | ||||
Country: Belgium | ||||||
Register of legal persons—commercial court: Antwerp, division Mechelen | ||||||
Website 2: | ||||||
E-mail address 2 : | ||||||
Company registration number | 0466.460.429 |
DATE 29-09-2022 of filing the most recent document mentioning the date of publication of the deed of incorporation and of the deed of amendment of the articles of association.
This filing concerns 3:
☒ the ANNUAL accounts in EURO (2 decimals)4 approved by the general meeting of 25-04-2023
☒ the OTHER DOCUMENTS
regarding
the financial year covering the period from 01-01-2022 to 31-12-2022
the preceding period of the annual accounts from 01-01-2021 to 31-12-2021
The amounts for the preceding period are / are not 5 identical to the ones previously published.
Total number of pages filed: 57 Numbers of the sections of the standard model form not filed because they serve no useful purpose: 6.1, 6.2.1, 6.2.4, 6.17, 7, 8, 9, 11, 12, 13, 14, 15
Signature (name and position) Stoffels IMC BV, represented by Dr. Paul Stoffels Director | Signature (name and position) Jérôme Contamine Director |
1 | Where appropriate, “in liquidation” is stated after the legal form. |
2 | Optional mention. |
3 | Tick the appropriate box(es). |
4 | If necessary, change to currency in which the amounts are expressed. |
5 | Strike out what does not apply. |
1/57
N°. | 0466.460.429 | F-cap 2.1 |
LIST OF DIRECTORS, BUSINESS MANAGERS AND AUDITORS AND
DECLARATION REGARDING A COMPLIMENTARY REVIEW OR
CORRECTION ASSIGNMENT
LIST OF DIRECTORS, BUSINESS MANAGERS AND AUDITORS
COMPLETE LIST with surname, first names, profession, place of residence (address, number, postal code and town) and position within the company
Stoffels IMC BV 0780.918.294
Generaal De Wittelaan L11, box A3, 2800 Mechelen, Belgium
Mandate: Director, start: 26-04-2022, end: 28-04-2026
Represented by:
1 Stoffels Paul
Parekh Raj | ||
Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium | ||
Mandate: Director, start: 28-04-2021, end: 29-04-2025 | ||
Kerr Mary | ||
Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium | ||
Mandate: Director, start: 28-04-2020, end: 23-04-2024 | ||
Rowe Howard | ||
Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium | ||
Mandate: Director, start: 24-04-2018, end: 26-04-2022 | ||
Bosley Katrine | ||
Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium | ||
Mandate: Director, start: 28-04-2021, end: 26-04-2022 | ||
Guenter Peter | ||
Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium | ||
Mandate: Director, start: 30-04-2019, end: 25-04-2023 |
O’Day Daniel
Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium
Mandate: Director, start: 22-10-2019, end: 25-04-2023
Higgins Linda
Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium
Mandate: Director, start: 22-10-2019, end: 25-04-2023
Svanberg Elisabeth
Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium
Mandate: Director, start: 28-04-2020, end: 23-04-2024
Baker Dan
Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium
Mandate: Director, start: 26-04-2022, end: 28-04-2026
2/57
Nr. | 0466.460.429 | F-cap 2.1 |
LIST OF DIRECTORS, BUSINESS MANAGERS AND AUDITORS (continued from previous page)
Contamine Jérôme
Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium
Mandate: Director, start: 26-04-2022, end: 28-04-2026
Deloitte Bedrijfsrevisoren BV 0429.053.863
Gateway Building—Luchthaven Nationaal 1, box J, 1930 Zaventem, Belgium
Membership number: B00025
Mandate: Auditor, start: 28-04-2020, end: 25-04-2023
Represented by:
1 | Houthaeve Nico |
Gateway Building - Luchthaven Nationaal 1 , box J 1930 Zaventem Belgium
Bedrijfsrevisor, Membership number : A02260
3/57
N°. | 0466.460.429 | F-cap 2.2 |
DECLARATION REGARDING A COMPLIMENTARY REVIEW OR CORRECTION ASSIGNMENT
The managing board declares that not a single audit or correction assignment has been given to a person not authorized to do so by law, pursuant to articles 34 and 37 of the law of 22 April 1999 concerning accounting and tax professions.
The annual accounts were / were not * audited or corrected by an external accountant or by a company auditor who is not the statutory auditor.
If affirmative, should be mentioned hereafter: surname, first names, profession and address of each external accountant or company auditor and their membership number at their Institute, as well as the nature of their assignment:
A. | Bookkeeping of the company **, |
B. | Preparing the annual accounts **, |
C. | Auditing the annual accounts and/or |
D. | Correcting the annual accounts. |
If the tasks mentioned under A or B are executed by certified accountants or certified bookkeepers - tax experts, the following information can be mentioned hereafter: surname, first names, profession and address of each certified accountant or certified bookkeeper-tax expert and their membership number at the Institute of Accounting professionals and Tax Experts, as well as the nature of their assignment.
Surname, first names, profession and address | Membership number | Nature of the assignment (A, B, C and/or D) |
* | Strike out what does not apply. |
** | Optional mention. |
4/57
N°. | 0466.460.429 | F-cap 3.1 |
ANNUAL ACCOUNTS
BALANCE SHEET AFTER APPROPRIATION
Notes | Codes | Period | Preceding period | |||||||||||||
ASSETS | ||||||||||||||||
FORMATION EXPENSES | 6.1 | 20 | ||||||||||||||
|
|
|
| |||||||||||||
FIXED ASSETS | 21/28 | 287.678.343,32 | 107.304.404,99 | |||||||||||||
|
|
|
| |||||||||||||
Intangible fixed assets | 6.2 | 21 | 18.165.368,92 | 48.289.584,03 | ||||||||||||
Tangible fixed assets | 6.3 | 22/27 | 17.595.160,96 | 15.697.365,57 | ||||||||||||
Land and buildings | 22 | 1.795.863,63 | 2.642.251,91 | |||||||||||||
Plant, machinery and equipment | 23 | 13.524.236,50 | 9.528.856,07 | |||||||||||||
Furniture and vehicles | 24 | 1.761.885,33 | 2.056.360,20 | |||||||||||||
Leasing and other similar rights | 25 | 0,00 | 0,00 | |||||||||||||
Other tangible fixed assets | 26 | 0,00 | 0,00 | |||||||||||||
Assets under construction and advance payments | 27 | 513.175,50 | 1.469.897,39 | |||||||||||||
Financial fixed assets | | 6.4 / 6.5.1 |
| 28 | 251.917.813,44 | 43.317.455,39 | ||||||||||
Affiliated Companies | 6.15 | 280/1 | 247.851.398,60 | 41.892.808,95 | ||||||||||||
Participating interests | 280 | 154.642.557,95 | 41.892.808,95 | |||||||||||||
Amounts receivable | 281 | 93.208.840,65 | ||||||||||||||
Other companies linked by participating interests | 6.15 | 282/3 | 1,00 | 1,00 | ||||||||||||
Participating interests | 282 | 1,00 | 1,00 | |||||||||||||
Amounts receivable | 283 | |||||||||||||||
Other financial fixed assets | 284/8 | 4.066.413,84 | 1.424.645,44 | |||||||||||||
Shares | 284 | |||||||||||||||
Amounts receivable and cash guarantees | 285/8 | 4.066.413,84 | 1.424.645,44 |
5/57
N°. | 0466.460.429 | F-cap 3.1 |
Notes | Codes | Period | Preceding period | |||||||||||||
CURRENT ASSETS | 29/58 | 4.406.769.755,85 | 5.013.128.331,17 | |||||||||||||
|
|
|
| |||||||||||||
Amounts receivable after more than one year |
| 29 | 87.847.046,48 | 92.500.048,60 | ||||||||||||
Trade debtors | 290 | 0,00 | 0,00 | |||||||||||||
Other amounts receivable | 291 | 87.847.046,48 | 92.500.048,60 | |||||||||||||
Stocks and contracts in progress | 3 | 52.665.394,63 | 20.360.570,40 | |||||||||||||
Stocks | 30/36 | 52.665.394,63 | 20.360.570,40 | |||||||||||||
Raw materials and consumables |
| 30/31 | 39.071.495,63 | 14.350.538,85 | ||||||||||||
Work in progress | 32 | 5.790.624,30 | 1.376.208,24 | |||||||||||||
Finished goods | 33 | |||||||||||||||
Goods purchased for resale | 34 | 7.803.274,70 | 4.633.823,31 | |||||||||||||
Immovable property intended for sale |
| 35 | ||||||||||||||
Advance payments | 36 | |||||||||||||||
Contracts in progress | 37 | |||||||||||||||
Amounts receivable within one year | 40/41 | 154.703.979,26 | 209.445.490,09 | |||||||||||||
Trade debtors | 40 | 72.294.845,49 | 92.851.469,32 | |||||||||||||
Other amounts receivable | 41 | 82.409.133,77 | 116.594.020,77 | |||||||||||||
Current investents | 6.5.1 / 6.6 | 50/53 | 3.635.944.614,15 | 3.477.317.279,55 | ||||||||||||
Own shares | 50 | |||||||||||||||
Other investments | 51/53 | 3.635.944.614,15 | 3.477.317.279,55 | |||||||||||||
Cash at bank and in hand | 54/58 | 455.142.600,34 | 1.203.980.494,83 | |||||||||||||
Accruals and deferred income | 6.6 | 490/1 | 20.466.120,99 | 9.524.447,70 | ||||||||||||
|
|
|
| |||||||||||||
TOTAL ASSETS | 20/58 | 4.694.448.099,17 | 5.120.432.736,16 | |||||||||||||
|
|
|
|
6/57
N°. | 0466.460.429 | F-cap 3.2 |
Notes | Codes | Period | Preceding period | |||||||||||||
EQUITY AND LIABILITIES | ||||||||||||||||
EQUITY | 10/15 | 2.508.639.933,58 | 2.639.924.301,22 | |||||||||||||
|
|
|
| |||||||||||||
Contributions | 6.7.1 | 10/11 | 3.015.856.524,50 | 3.009.161.167,90 | ||||||||||||
Capital | 10 | 356.111.899,01 | 354.582.005,11 | |||||||||||||
Issued capital | 100 | 356.111.899,01 | 354.582.005,11 | |||||||||||||
Uncalled capital6 | 101 | |||||||||||||||
Beyond capital | 11 | 2.659.744.625,49 | 2.654.579.162,79 | |||||||||||||
Share premium account | 1100/10 | 2.659.744.625,49 | 2.654.579.162,79 | |||||||||||||
Other | 1109/19 | |||||||||||||||
Revaluation surpluses | 12 | |||||||||||||||
Reserves | 13 | |||||||||||||||
Reserves not available | 130/1 | |||||||||||||||
Legal reserve | 130 | |||||||||||||||
Reserves not available statutorily | 1311 | |||||||||||||||
Purchase of own shares | 1312 | |||||||||||||||
Financial support | 1313 | |||||||||||||||
Other | 1319 | |||||||||||||||
Untaxed reserves | 132 | |||||||||||||||
Available reserves | 133 | |||||||||||||||
Accumulated profits (losses) | (+)/(-) | 14 | -507.216.590,92 | -369.236.866,68 | ||||||||||||
Capital subsidies | 15 | |||||||||||||||
Advance to shareholders on the distribution of net assets 7 |
| 19 | ||||||||||||||
PROVISIONS AND DEFERRED TAXES |
| 16 | 9.751.646,72 | 8.885.432,84 | ||||||||||||
|
|
|
| |||||||||||||
Provisions for liabilities and charges | 160/5 | 9.751.646,72 | 8.885.432,84 | |||||||||||||
Pensions and similar obligations | 160 | |||||||||||||||
Taxes | 161 | |||||||||||||||
Major repairs and maintenance | 162 | |||||||||||||||
Environmental obligations | 163 | |||||||||||||||
Other liabilities and charges | 6.8 | 164/5 | 9.751.646,72 | 8.885.432,84 | ||||||||||||
Deferred taxes | 168 |
6 | Amount to be deducted from the issued capital. |
7 | Amount to be deducted from the other components of equity. |
7/57
N°. | 0466.460.429 | F-cap 3.2 |
Notes | Codes | Period | Preceding period | |||||||||||||
AMOUNTS PAYABLE | 17/49 | 2.176.056.518,87 | 2.471.623.002,10 | |||||||||||||
|
|
|
| |||||||||||||
Amounts payable after more than one year | 6.9 | 17 | 1.500.000,00 | |||||||||||||
Financial debts | 170/4 | |||||||||||||||
Subordinated loans | 170 | |||||||||||||||
Unsubordinated debentures | 171 | |||||||||||||||
Leasing and other similar obligations | 172 | |||||||||||||||
Credit institutions | 173 | |||||||||||||||
Other loans | 174 | |||||||||||||||
Trade debts | 175 | |||||||||||||||
Suppliers | 1750 | |||||||||||||||
Bills of exchange payable | 1751 | |||||||||||||||
Advance payments on contracts in progress | 176 | |||||||||||||||
Other amounts payable | 178/9 | 1.500.000,00 | ||||||||||||||
Amounts payable within one year | 6.9 | 42/48 | 300.241.235,39 | 240.616.552,18 | ||||||||||||
Current portion of amounts payable after more than one year falling due within one year | 42 | |||||||||||||||
Financial debts | 43 | 652.248,54 | ||||||||||||||
Credit institutions | 430/8 | |||||||||||||||
Other loans | 439 | 652.248,54 | ||||||||||||||
Trade debts | 44 | 67.168.085,94 | 149.436.470,22 | |||||||||||||
Suppliers | 440/4 | 67.168.085,94 | 149.436.470,22 | |||||||||||||
Bills of exchange payable | 441 | |||||||||||||||
Advance payments on contracts in progress | 46 | |||||||||||||||
Taxes, remuneration and social security | 6.9 | 45 | 25.642.149,30 | 16.705.137,72 | ||||||||||||
Taxes | 450/3 | 2.045.671,99 | 1.634.221,76 | |||||||||||||
Remuneration and social security | 454/9 | 23.596.477,31 | 15.070.915,96 | |||||||||||||
Other amounts payable | 47/48 | 207.431.000,15 | 73.822.695,70 | |||||||||||||
Accruals and deferred income | 6.9 | 492/3 | 1.875.815.283,48 | 2.229.506.449,92 | ||||||||||||
|
|
|
| |||||||||||||
TOTAL LIABILITIES | 10/49 | 4.694.448.099,17 | 5.120.432.736,16 | |||||||||||||
|
|
|
|
6 | Amount to be deducted from the issued capital. |
7 | Amount to be deductedfrom the other components of equity. |
8/57
N°. | 0466.460.429 | F-cap 4 |
PROFIT AND LOSS ACCOUNT
Notes | Codes | Period | Preceding period | |||||||||||||||||
Operating income | 70/76A | 785.283.036,65 | 916.045.607,30 | |||||||||||||||||
Turnover | 6.10 | 70 | 418.495.174,45 | 503.389.557,93 | ||||||||||||||||
Stocks of finished goods and work and contracts in progress: increase (decrease) | (+ | )/(-) | 71 | 4.414.416,06 | 1.376.208,24 | |||||||||||||||
Produced fixed assets | 72 | 349.507.630,25 | 392.744.362,35 | |||||||||||||||||
Other operating income | 6.10 | 74 | 12.846.815,89 | 18.535.478,78 | ||||||||||||||||
Non-recurring operating income | 6.12 | 76A | 19.000,00 | |||||||||||||||||
Operating charges | 60/66A | 1.016.944.469,75 | 1.107.719.288,17 | |||||||||||||||||
Goods for resale, raw materials and consumables | 60 | 19.860.033,19 | 13.057.606,20 | |||||||||||||||||
Purchases | 600/8 | 47.750.441,36 | 31.687.042,95 | |||||||||||||||||
Stocks: decrease (increase) | (+ | )/(-) | 609 | -27.890.408,17 | 18.629.436,75 | |||||||||||||||
Services and other goods | 61 | 420.835.394,77 | 500.011.877,25 | |||||||||||||||||
Remuneration, social security and pensions | (+ | )/(-) | 6.10 | 62 | 77.772.120,25 | 70.359.917,83 | ||||||||||||||
Amortisations of and other amounts written down on formation expenses, intangible and tangible fixed assets | 630 | 357.368.023,96 | 401.835.300,64 | |||||||||||||||||
Amounts written down on stocks, contracts in progress and trade debtors: additions (write-backs) (+)/(-) | 6.10 | 631/4 | 1.239.142,18 | 7.918,89 | ||||||||||||||||
Provisions for liabilities and charges: appropriations (uses and write-backs) (+)/(-) | 6.10 | 635/8 | 866.213,88 | -2.325.058,70 | ||||||||||||||||
Other operating charges | 6.10 | 640/8 | 102.149.120,04 | 120.703.732,63 | ||||||||||||||||
Operating charges reported as assets under restructuring costs | (- | ) | 649 | |||||||||||||||||
Non-recurring operating charges | 6.12 | 66A | 36.854.421,48 | 4.067.993,43 | ||||||||||||||||
Operating profit (loss) | (+ | )/(-) | 9901 | -231.661.433,10 | -191.673.680,87 |
9/57
N°. | 0466.460.429 | F-cap 4 |
Notes | Codes | Period | Preceding period | |||||||||||||
Financial income | 75/76B | 135.553.985,24 | 119.235.560,98 | |||||||||||||
Recurring financial income | 75 | 135.553.985,24 | 85.764.548,98 | |||||||||||||
Income from financial fixed assets | 750 | 10.500.604,22 | 582,94 | |||||||||||||
Income from current assets | 751 | 22.459.253,19 | 3.047.683,63 | |||||||||||||
Other financial income | 6.11 | 752/9 | 102.594.127,83 | 82.716.282,41 | ||||||||||||
Non-recurring financial income | 6.12 | 76B | 0,00 | 33.471.012,00 | ||||||||||||
Financial charges | 6.11 | 65/66B | 60.963.867,63 | 40.455.192,40 | ||||||||||||
Recurring financial charges | 65 | 60.963.867,63 | 28.125.050,74 | |||||||||||||
Debt charges | 650 | 11.085.226,07 | 14.508.804,19 | |||||||||||||
Amounts written down on current assets other than stocks, contracts in progress and trade debtors: additions (write-backs) | (+)/(-) | 651 | 0,00 | 6.403.525,27 | ||||||||||||
Other financial charges | 652/9 | 49.878.641,56 | 7.212.721,28 | |||||||||||||
Non-recurring financial charges | 6.12 | 66B | 0,00 | 12.330.141,66 | ||||||||||||
Profit (Loss) for the period before taxes | (+)/(-) | 9903 | -157.071.315,49 | -112.893.312,29 | ||||||||||||
Transfer from deferred taxes | 780 | |||||||||||||||
Transfer to deferred taxes | 680 | |||||||||||||||
Income taxes on the result | (+)/(-) 6.13 | 67/77 | -19.091.591,25 | -20.155.885,92 | ||||||||||||
Taxes | 670/3 | 196.796,56 | 700.111,66 | |||||||||||||
Adjustment of income taxes and write-back of tax provisions | 77 | 19.288.387,81 | 20.855.997,58 | |||||||||||||
Profit (Loss) of the period | (+)/(-) | 9904 | -137.979.724,24 | -92.737.426,37 | ||||||||||||
Transfer from untaxed reserves | 789 | |||||||||||||||
Transfer to untaxed reserves | 689 | |||||||||||||||
Profit (Loss) of the period available for appropriation | (+)/(-) | 9905 | -137.979.724,24 | -92.737.426,37 |
10/57
N°. | 0466.460.429 | F-cap 5 |
APPROPRIATION ACCOUNT
Codes | Period | Preceding period | ||||||||||||||
Profit (Loss) to be appropriated | (+)/(-) | 9906 | -507.216.590,92 | -369.236.866,68 | ||||||||||||
Profit (Loss) of the period available for appropriation | (+)/(-) | (9905 | ) | -137.979.724,24 | -92.737.426,37 | |||||||||||
Profit (Loss) of the preceding period brought forward | (+)/(-) | 14P | -369.236.866,68 | -276.499.440,31 | ||||||||||||
Transfers from equity | 791/2 | |||||||||||||||
from contributions | 791 | |||||||||||||||
from reserves | 792 | |||||||||||||||
Appropriations to equity | 691/2 | |||||||||||||||
to contributions | 691 | |||||||||||||||
to legal reserve | 6920 | |||||||||||||||
to other reserves | 6921 | |||||||||||||||
Profit (loss) to be carried forward | (+)/(-) | (14 | ) | -507.216.590,92 | -369.236.866,68 | |||||||||||
Shareholders’ contribution in respect of losses | 794 | |||||||||||||||
Profit to be distributed | 694/7 | |||||||||||||||
Compensation for contributions | 694 | |||||||||||||||
Directors or managers | 695 | |||||||||||||||
Employees | 696 | |||||||||||||||
Other beneficiaries | 697 |
11/57
N°. | 0466.460.429 | F-cap 6.2.2 |
Codes | Period | Preceding period | ||||||||||||||
RESEARCH COSTS MADE IN A PERIOD THAT STARTED BEFORE 1 JANUARY 2016 | ||||||||||||||||
Acquisition value at the end of the period | 8055P | xxxxxxxxxxxxxxx | 392.970.251,41 | |||||||||||||
Movements during the period | ||||||||||||||||
Acquisitions, including produced fixed assets | 8025 | |||||||||||||||
Sales and disposals | 8035 | |||||||||||||||
Transfers from one heading to another | (+ | )/(-) | 8045 | |||||||||||||
Acquisition value at the end of the period | 8055 | 392.970.251,41 | ||||||||||||||
Amortisations and amounts written down at the end of the period | 8125P | xxxxxxxxxxxxxxx | 392.970.251,41 | |||||||||||||
Movements during the period | ||||||||||||||||
Recorded | 8075 | |||||||||||||||
Written back | 8085 | |||||||||||||||
Acquisitions from third parties | 8095 | |||||||||||||||
Cancelled owing to sales and disposals | 8105 | |||||||||||||||
Transferred from one heading to another | (+ | )/(-) | 8115 | |||||||||||||
Amortisations and amounts written down at the end of the period | 8125 | 392.970.251,41 | ||||||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | 81312 | 0,00 | ||||||||||||||
|
| |||||||||||||||
Codes | Period | |||||||||||||||
RESEARCH COSTS MADE IN A PERIOD THAT STARTED AFTER 31 DECEMBER 2015 | ||||||||||||||||
Acquisition value at the end of the period | 8056 | 2.211.375.028,18 | ||||||||||||||
Amortisations and amounts written down at the end of the period | 8126 | 2.211.375.028,18 | ||||||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | 81313 | 0,00 | ||||||||||||||
|
|
12/57
N°. | 0466.460.429 | F-cap 6.2.3 |
Codes | Period | Preceding period | ||||||||||||
CONCESSIONS, PATENTS LICENSES, KNOW-HOW, BRANDS AND SIMILAR RIGHTS | ||||||||||||||
Acquisition value at the end of the period | 8052P | xxxxxxxxxxxxxxx | 930.540.095,44 | |||||||||||
Movements during the period | ||||||||||||||
Acquisitions, including produced fixed assets | 8022 | 359.619.814,09 | ||||||||||||
Sales and disposals | 8032 | 36.852.270,40 | ||||||||||||
Transfers from one heading to another | (+ | )/(-) | 8042 | |||||||||||
Acquisition value at the end of the period | 8052 | 1.253.307.639,13 | ||||||||||||
Amortisations and amounts written down at the end of the period | 8122P | xxxxxxxxxxxxxxx | 882.250.511,41 | |||||||||||
Movements during the period | ||||||||||||||
Recorded | 8072 | 353.623.889,76 | ||||||||||||
Written back | 8082 | |||||||||||||
Acquisitions from third parties | 8092 | |||||||||||||
Cancelled owing to sales and disposals | 8102 | 732.130,96 | ||||||||||||
Transfers from one heading to another | (+ | )/(-) | 8112 | |||||||||||
Amortisations and amounts written down at the end of the period | 8122 | 1.235.142.270,21 | ||||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | 211 | 18.165.368,92 | ||||||||||||
|
13/57
N°. | 0466.460.429 | F-cap 6.2.5 |
Codes | Period | Preceding period | ||||||||||||
ADVANCE PAYMENTS | ||||||||||||||
Acquisition value at the end of the period | 8054P | xxxxxxxxxxxxxxx | 0,00 | |||||||||||
Movements during the period | ||||||||||||||
Acquisitions, including produced fixed assets | 8024 | |||||||||||||
Sales and disposals | 8034 | |||||||||||||
Transfers from one heading to another | (+ | )/(-) | 8044 | |||||||||||
Acquisition value at the end of the period | 8054 | 0,00 | ||||||||||||
Amortisations and amounts written down at the end of the period | 8124P | xxxxxxxxxxxxxxx | ||||||||||||
Movements during the period | ||||||||||||||
Recorded | 8074 | |||||||||||||
Written back | 8084 | |||||||||||||
Acquisitions from third parties | 8094 | |||||||||||||
Cancelled owing to sales and disposals | 8104 | |||||||||||||
Transferred from one heading to another | (+ | )/(-) | 8114 | |||||||||||
Amortisations and amounts written down at the end of the period | 8124 | |||||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | 213 | 0,00 | ||||||||||||
|
14/57
N°. | 0466.460.429 | F-cap 6.3.1 |
STATEMENT OF TANGIBLE FIXED ASSETS
Codes | Period | Preceding period | ||||||||||||
LAND AND BUILDINGS | ||||||||||||||
Acquisition value at the end of the period | 8191P | xxxxxxxxxxxxxxx | 5.408.825,29 | |||||||||||
Movements during the period | ||||||||||||||
Acquisitions, including produced fixed assets | 8161 | 459.256,62 | ||||||||||||
Sales and disposals | 8171 | 461.523,83 | ||||||||||||
Transfers from one heading to another | (+ | )/(-) | 8181 | |||||||||||
Acquisition value at the end of the period | 8191 | 5.406.558,08 | ||||||||||||
Revaluation surpluses at the end of the period | 8251P | xxxxxxxxxxxxxxx | ||||||||||||
Movements during the period | ||||||||||||||
Recorded | 8211 | |||||||||||||
Acquisitions from third parties | 8221 | |||||||||||||
Cancelled | 8231 | |||||||||||||
Transferred from one heading to another | (+ | )/(-) | 8241 | |||||||||||
Revaluation surpluses at the end of the period | 8251 | |||||||||||||
Amortisations and amounts written down at the end of the period | 8321P | xxxxxxxxxxxxxxx | 2.766.573,38 | |||||||||||
Movements during the period | ||||||||||||||
Recorded | 8271 | 1.039.300,55 | ||||||||||||
Written back | 8281 | |||||||||||||
Acquisitions from third parties | 8291 | |||||||||||||
Cancelled owing to sales and disposals | 8301 | 195.179,48 | ||||||||||||
Transferred from one heading to another | (+ | )/(-) | 8311 | |||||||||||
Amortisations and amounts written down at the end of the period | 8321 | 3.610.694,45 | ||||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | (22 | ) | 1.795.863,63 | |||||||||||
|
15/57
N°. | 0466.460.429 | F-cap 6.3.2 |
Codes | Period | Preceding period | ||||||||||||||
PLANT, MACHINERY AND EQUIPMENT | ||||||||||||||||
Acquisition value at the end of the period | 8192P | xxxxxxxxxxxxxxx | 20.999.579,68 | |||||||||||||
Movements during the period | ||||||||||||||||
Acquisitions, including produced fixed assets | 8162 | 6.031.645,04 | ||||||||||||||
Sales and disposals | 8172 | 28.328,57 | ||||||||||||||
Transfers from one heading to another | (+ | )/(-) | 8182 | |||||||||||||
Acquisition value at the end of the period | 8192 | 27.002.896,15 | ||||||||||||||
Revaluation surpluses at the end of the period | 8252P | xxxxxxxxxxxxxxx | ||||||||||||||
Movements during the period | ||||||||||||||||
Recorded | 8212 | |||||||||||||||
Acquisitions from third parties | 8222 | |||||||||||||||
Cancelled | 8232 | |||||||||||||||
Transferred from one heading to another | (+ | )/(-) | 8242 | |||||||||||||
Revaluation surpluses at the end of the period | 8252 | |||||||||||||||
Amortisations and amounts written down at the end of the period | 8322P | xxxxxxxxxxxxxxx | 11.470.723,61 | |||||||||||||
Movements during the period | ||||||||||||||||
Recorded | 8272 | 2.015.641,25 | ||||||||||||||
Written back | 8282 | |||||||||||||||
Acquisitions from third parties | 8292 | |||||||||||||||
Cancelled owing to sales and disposals | 8302 | 7.705,21 | ||||||||||||||
Transferred from one heading to another | (+ | )/(-) | 8312 | |||||||||||||
Amortisations and amounts written down at the end of the period | 8322 | 13.478.659,65 | ||||||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | (23 | ) | 13.524.236,50 | |||||||||||||
|
|
16/57
N°. | 0466.460.429 | F-cap 6.3.3 |
Codes | Period | Preceding period | ||||||||||||||
FURNITURE AND VEHICLES | ||||||||||||||||
Acquisition value at the end of the period | 8193P | xxxxxxxxxxxxxxx | 3.458.047,35 | |||||||||||||
Movements during the period | ||||||||||||||||
Acquisitions, including produced fixed assets | 8163 | 408.079,70 | ||||||||||||||
Sales and disposals | 8173 | 408.681,81 | ||||||||||||||
Transfers from one heading to another | (+ | )/(-) | 8183 | |||||||||||||
Acquisition value at the end of the period | 8193 | 3.457.445,24 | ||||||||||||||
Revaluation surpluses at the end of the period | 8253P | xxxxxxxxxxxxxxx | ||||||||||||||
Movements during the period | ||||||||||||||||
Recorded | 8213 | |||||||||||||||
Acquisitions from third parties | 8223 | |||||||||||||||
Cancelled | 8233 | |||||||||||||||
Transfers from one heading to another | (+ | )/(-) | 8243 | |||||||||||||
Revaluation surpluses at the end of the period | 8253 | |||||||||||||||
Amortisations and amounts written down at the end of the period | 8323P | xxxxxxxxxxxxxxx | 1.401.687,15 | |||||||||||||
Movements during the period | ||||||||||||||||
Recorded | 8273 | 689.192,40 | ||||||||||||||
Written back | 8283 | |||||||||||||||
Acquisitions from third parties | 8293 | |||||||||||||||
Cancelled owing to sales and disposals | 8303 | 395.319,64 | ||||||||||||||
Transfers from one heading to another | (+ | )/(-) | 8313 | |||||||||||||
Amortisations and amounts written down at the end of the period | 8323 | 1.695.559,91 | ||||||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | (24 | ) | 1.761.885,33 | |||||||||||||
|
|
17/57
N°. | 0466.460.429 | F-cap 6.3.4 |
Codes | Period | Preceding period | ||||||||||||
LEASING AND OTHER SIMILAR RIGHTS | ||||||||||||||
Acquisition value at the end of the period | 8194P | xxxxxxxxxxxxxxx | 251.108,19 | |||||||||||
Movements during the period | ||||||||||||||
Acquisitions, including produced fixed assets | 8164 | |||||||||||||
Sales and disposals | 8174 | 251.108,19 | ||||||||||||
Transfers from one heading to another | (+ | )/(-) | 8184 | |||||||||||
Acquisition value at the end of the period | 8194 | 0,00 | ||||||||||||
Revaluation surpluses at the end of the period | 8254P | xxxxxxxxxxxxxxx | ||||||||||||
Movements during the period | ||||||||||||||
Recorded | 8214 | |||||||||||||
Acquisitions from third parties | 8224 | |||||||||||||
Cancelled | 8234 | |||||||||||||
Transfers from one heading to another | (+ | )/(-) | 8244 | |||||||||||
Revaluation surpluses at the end of the period | 8254 | |||||||||||||
Amortisations and amounts written down at the end of the period | 8324P | xxxxxxxxxxxxxxx | 251.108,19 | |||||||||||
Movements during the period | ||||||||||||||
Recorded | 8274 | |||||||||||||
Written back | 8284 | |||||||||||||
Acquisitions from third parties | 8294 | |||||||||||||
Cancelled owing to sales and disposals | 8304 | 251.108,19 | ||||||||||||
Transferred from one heading to another | (+ | )/(-) | 8314 | |||||||||||
Amortisations and amounts written down at the end of the period | 8324 | 0,00 | ||||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | (25 | ) | 0,00 | |||||||||||
| ||||||||||||||
Of which | ||||||||||||||
Land and buildings | 250 | |||||||||||||
Plant, machinery and equipment | 251 | |||||||||||||
Furniture and vehicles | 252 |
18/57
N°. | 0466.460.429 | F-cap 6.3.5 |
Codes | Period | Preceding period | ||||||||||||||
OTHER TANGIBLE FIXED ASSETS | ||||||||||||||||
Acquisition value at the end of the period | 8195P | xxxxxxxxxxxxxxx | ||||||||||||||
Movements during the period | ||||||||||||||||
Acquisitions, including produced fixed assets | 8165 | |||||||||||||||
Sales and disposals | 8175 | |||||||||||||||
Transfers from one heading to another | (+ | )/(-) | 8185 | |||||||||||||
Acquisition value at the end of the period | 8195 | |||||||||||||||
Revaluation surpluses at the end of the period | 8255P | xxxxxxxxxxxxxxx | ||||||||||||||
Movements during the period | ||||||||||||||||
Recorded | 8215 | |||||||||||||||
Acquisitions from third parties | 8225 | |||||||||||||||
Cancelled | 8235 | |||||||||||||||
Transferred from one heading to another | (+ | )/(-) | 8245 | |||||||||||||
Revaluation surpluses at the end of the period | 8255 | |||||||||||||||
Amortisations and amounts written down at the end of the period | 8325P | xxxxxxxxxxxxxxx | ||||||||||||||
Movements during the period | ||||||||||||||||
Recorded | 8275 | |||||||||||||||
Written back | 8285 | |||||||||||||||
Acquisitions from third parties | 8295 | |||||||||||||||
Cancelled owing to sales and disposals | 8305 | |||||||||||||||
Transferred from one heading to another | (+ | )/(-) | 8315 | |||||||||||||
Amortisations and amounts written down at the end of the period | 8325 | |||||||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | (26 | ) | 0,00 | |||||||||||||
|
|
19/57
N°. | 0466.460.429 | F-cap 6.3.6 |
Codes | Period | Preceding period | ||||||||||||
ASSETS UNDER CONSTRUCTION AND ADVANCE PAYMENTS | ||||||||||||||
Acquisition value at the end of the period | 8196P | xxxxxxxxxxxxxxx | 1.469.897,39 | |||||||||||
Movements during the period | ||||||||||||||
Acquisitions, including produced fixed assets | 8166 | |||||||||||||
Sales and disposals | 8176 | 956.721,89 | ||||||||||||
Transfers from one heading to another | (+ | )/(-) | 8186 | |||||||||||
Acquisition value at the end of the period | 8196 | 513.175,50 | ||||||||||||
Revaluation surpluses at the end of the period | 8256P | xxxxxxxxxxxxxxx | ||||||||||||
Movements during the period | ||||||||||||||
Recorded | 8216 | |||||||||||||
Acquisitions from third parties | 8226 | |||||||||||||
Cancelled | 8236 | |||||||||||||
Transferred from one heading to another | (+ | )/(-) | 8246 | |||||||||||
Revaluation surpluses at the end of the period | 8256 | |||||||||||||
Amortisations and amounts written down at the end of the period | 8326P | xxxxxxxxxxxxxxx | ||||||||||||
Movements during the period | ||||||||||||||
Recorded | 8276 | |||||||||||||
Written back | 8286 | |||||||||||||
Acquisitions from third parties | 8296 | |||||||||||||
Cancelled owing to sales and disposals | 8306 | |||||||||||||
Transferred from one heading to another | (+ | )/(-) | 8316 | |||||||||||
Amortisations and amounts written down at the end of the period | 8326 | |||||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | (27 | ) | 513.175,50 | |||||||||||
|
20/57
N°. | 0466.460.429 | F-cap 6.4.1 |
STATEMENT OF FINANCIAL FIXED ASSETS
Codes | Period | Preceding period | ||||||||||
AFFILIATED COMPANIES - PARTICIPATING INTERESTS AND SHARES | ||||||||||||
Acquisition value at the end of the period | 8391P | xxxxxxxxxxxxxxx | 55.951.485,95 | |||||||||
Movements during the period | ||||||||||||
Acquisitions | 8361 | 112.749.749,00 | ||||||||||
Sales and disposals | 8371 | 0,00 | ||||||||||
Transfers from one heading to another | (+)/(-) | 8381 | ||||||||||
Acquisition value at the end of the period | 8391 | 168.701.234,95 | ||||||||||
Revaluation surpluses at the end of the period | 8451P | xxxxxxxxxxxxxxx | ||||||||||
Movements during the period | ||||||||||||
Recorded | 8411 | |||||||||||
Acquisitions from third parties | 8421 | |||||||||||
Cancelled | 8431 | |||||||||||
Transferred from one heading to another | (+)/(-) | 8441 | ||||||||||
Revaluation surpluses at the end of the period | 8451 | |||||||||||
Amounts written down at the end of the period | 8521P | xxxxxxxxxxxxxxx | 14.058.677,00 | |||||||||
Movements during the period | ||||||||||||
Recorded | 8471 | |||||||||||
Written back | 8481 | |||||||||||
Acquisitions from third parties | 8491 | |||||||||||
Cancelled owing to sales and disposals | 8501 | |||||||||||
Transferred from one heading to another | (+)/(-) | 8511 | ||||||||||
Amounts written down at the end of the period | 8521 | 14.058.677,00 | ||||||||||
Uncalled amounts at the end of the period | 8551P | xxxxxxxxxxxxxxx | ||||||||||
Movements during the period | (+)/(-) | 8541 | ||||||||||
Uncalled amounts at the end of the period | 8551 | |||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | (280 | ) | 154.642.557,95 | |||||||||
| ||||||||||||
AFFILIATED COMPANIES - AMOUNTS RECEIVABLE | ||||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | 281P | xxxxxxxxxxxxxxx | ||||||||||
| ||||||||||||
Movements during the period | ||||||||||||
Appropriations | 8581 | 93.208.840,65 | ||||||||||
Repayments | 8591 | |||||||||||
Amounts written down | 8601 | |||||||||||
Amounts written back | 8611 | |||||||||||
Exchange differences | (+)/(-) | 8621 | ||||||||||
Other movements | (+)/(-) | 8631 | ||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | (281 | ) | 93.208.840,65 | |||||||||
| ||||||||||||
ACCUMULATED AMOUNTS WRITTEN DOWN ON AMOUNTS | ||||||||||||
RECEIVABLE AT END OF THE PERIOD | 8651 | |||||||||||
|
21/57
N°. | 0466.460.429 | F-cap 6.4.2 |
Codes | Period | Preceding period | ||||||||||
COMPANIES LINKED BY PARTICIPATING INTERESTS - PARTICIPATING INTERESTS AND SHARES | ||||||||||||
Acquisition value at the end of the period | 8392P | xxxxxxxxxxxxxxx | 1,00 | |||||||||
Movements during the period | ||||||||||||
Acquisitions | 8362 | |||||||||||
Sales and disposals | 8372 | |||||||||||
Transfers from one heading to another | (+)/(-) | 8382 | ||||||||||
Acquisition value at the end of the period | 8392 | 1,00 | ||||||||||
Revaluation surpluses at the end of the period | 8452P | xxxxxxxxxxxxxxx | ||||||||||
Movements during the period | ||||||||||||
Recorded | 8412 | |||||||||||
Acquisitions from third parties | 8422 | |||||||||||
Cancelled | 8432 | |||||||||||
Transferred from one heading to another | (+)/(-) | 8442 | ||||||||||
Revaluation surpluses at the end of the period | 8452 | |||||||||||
Amounts written down at the end of the period | 8522P | xxxxxxxxxxxxxxx | ||||||||||
Movements during the period | ||||||||||||
Recorded | 8472 | |||||||||||
Written back | 8482 | |||||||||||
Acquisitions from third parties | 8492 | |||||||||||
Cancelled owing to sales and disposals | 8502 | |||||||||||
Transferred from one heading to another | (+)/(-) | 8512 | ||||||||||
Amounts written down at the end of the period | 8522 | |||||||||||
Uncalled amounts at the end of the period | 8552P | xxxxxxxxxxxxxxx | ||||||||||
Movements during the period | (+)/(-) | 8542 | ||||||||||
Uncalled amounts at the end of the period | 8552 | |||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | (282 | ) | 1,00 | |||||||||
| ||||||||||||
COMPANIES LINKED BY PARTICIPATING INTERESTS - AMOUNTS RECEIVABLE | ||||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | 283P | xxxxxxxxxxxxxxx | ||||||||||
| ||||||||||||
Movements during the period | ||||||||||||
Appropriations | 8582 | |||||||||||
Repayments | 8592 | |||||||||||
Amounts written down | 8602 | |||||||||||
Amounts written back | 8612 | |||||||||||
Exchange differences | (+)/(-) | 8622 | ||||||||||
Other movements | (+)/(-) | 8632 | ||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | (283 | ) | ||||||||||
ACCUMULATED AMOUNTS WRITTEN DOWN ON AMOUNTS RECEIVABLE AT END OF THE PERIOD | 8652 |
22/57
N°. | 0466.460.429 | F-cap 6.4.3 |
Codes | Period | Preceding period | ||||||||||
OTHER COMPANIES - PARTICIPATING INTERESTS AND SHARES | ||||||||||||
Acquisition value at the end of the period | 8393P | xxxxxxxxxxxxxxx | 2.670.464,66 | |||||||||
Movements during the period | ||||||||||||
Acquisitions | 8363 | |||||||||||
Sales and disposals | 8373 | 2.670.464,66 | ||||||||||
Transfers from one heading to another | (+)/(-) | 8383 | ||||||||||
Acquisition value at the end of the period | 8393 | 0,00 | ||||||||||
Revaluation surpluses at the end of the period | 8453P | xxxxxxxxxxxxxxx | ||||||||||
Movements during the period | ||||||||||||
Recorded | 8413 | |||||||||||
Acquisitions from third parties | 8423 | |||||||||||
Cancelled | 8433 | |||||||||||
Transferred from one heading to another | (+)/(-) | 8443 | ||||||||||
Revaluation surpluses at the end of the period | 8453 | |||||||||||
Amounts written down at the end of the period | 8523P | xxxxxxxxxxxxxxx | 2.670.464,66 | |||||||||
Movements during the period | ||||||||||||
Recorded | 8473 | |||||||||||
Written back | 8483 | |||||||||||
Acquisitions from third parties | 8493 | |||||||||||
Cancelled owing to sales and disposals | 8503 | 2.670.464,66 | ||||||||||
Transferred from one heading to another | (+)/(-) | 8513 | ||||||||||
Amounts written down at the end of the period | 8523 | 0,00 | ||||||||||
Uncalled amounts at the end of the period | 8553P | xxxxxxxxxxxxxxx | ||||||||||
Movements during the period | (+)/(-) | 8543 | ||||||||||
Uncalled amounts at the end of the period | 8553 | |||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | (284 | ) | ||||||||||
| ||||||||||||
OTHER COMPANIES - AMOUNTS RECEIVABLE | ||||||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | 285/8P | xxxxxxxxxxxxxxx | 1.424.645,44 | |||||||||
|
|
| ||||||||||
Movements during the period | ||||||||||||
Appropriations | 8583 | 2.500.000,00 | ||||||||||
Repayments | 8593 | |||||||||||
Amounts written down | 8603 | |||||||||||
Amounts written back | 8613 | |||||||||||
Exchange differences | (+)/(-) | 8623 | ||||||||||
Other movements | (+)/(-) | 8633 | 141.768,40 | |||||||||
NET BOOK VALUE AT THE END OF THE PERIOD | (285/8 | ) | 4.066.413,84 | |||||||||
| ||||||||||||
ACCUMULATED AMOUNTS WRITTEN DOWN ON AMOUNTS | ||||||||||||
RECEIVABLE AT END OF THE PERIOD | 8653 | |||||||||||
|
23/57
N°. | 0466.460.429 | F-cap 6.5.1 |
PARTICIPATING INTERESTS INFORMATION
PARTICIPATING INTERESTS AND OTHER RIGHTS IN OTHER COMPANIES
The following list mentions the companies in which the company holds a participating interest (recorded in headings 280 and 282 of assets), as well as the companies in which the company holds rights (recorded in headings 284 and 51/53 of assets) for an amount of at least 10% of the capital, the equity or a class of shares of the company.
NAME, full address of the REGISTERED OFFICE and, for an entity governed by Belgian law, the COMPANY REGISTRATION NUMBER | Rights held | Data extracted from the most recent annual accounts | ||||||||||||||||||||||||||||
Nature | Directly | Subs- idiaries | Annual accounts as per | Cur- | Equity | Net result | ||||||||||||||||||||||||
Number | % | % | rency code | (+) or (-) (in units) | ||||||||||||||||||||||||||
Galapagos BV Foreign company Zernikedreef 16 2333 CL Leiden Netherlands 807938397B01 | Registered shares | 31-12-2022 | EUR | 2.616.058 | -9.677.425 | |||||||||||||||||||||||||
Galapagos Biotech Limited Foreign company Salisbury House, Station CB1 2LA Cambridgeshire United Kingdom 203017668 | 200 | 100,00 | 0,00 | 31-12-2022 | GBP | 11.897.352 | 1.618 | |||||||||||||||||||||||
Registered shares | 84.700.014 | 100,00 | 0,00 | |||||||||||||||||||||||||||
Galapagos SASU Foreign company Avenue Gaston Roussel 102 93230 Romainville France 27440348480 | Registered shares | 31-12-2022 | EUR | 152.358.200 | 16.082.808 | |||||||||||||||||||||||||
Galapagos GmbH Foreign company Aeschenvorstadt 71 4051 Basel Switzerland CHE388581566 | Registered shares | 51.199 | 100,00 | 0,00 | 31-12-2022 | CHF | 6.477.494 | 1.773.722 | ||||||||||||||||||||||
Galapagos Real Estate Belgium Private limited company Generaal De Wittelaan L11 , box A3 2800 Mechelen Belgium 0714.965.620 | Registered shares | 200 | 100,00 | 0,00 | 31-12-2022 | EUR | 190.478 | -449.845 | ||||||||||||||||||||||
Galapagos Biopharma Belgium BV Private limited company Generaal De Wittelaan L11 , box A3 2800 Mechelen Belgium 0727.786.248 | 1.120 | 100,00 | 0,00 | 31-12-2022 | EUR | 704.100 | 210.444 | |||||||||||||||||||||||
Registered shares | 500.000 | 100,00 | 0,00 |
24/57
N°. | 0466.460.429 | F-cap 6.5.1 |
PARTICIPATING INTERESTS INFORMATION
PARTICIPATING INTERESTS AND OTHER RIGHTS IN OTHER COMPANIES
The following list mentions the companies in which the company holds a participating interest (recorded in headings 280 and 282 of assets), as well as the companies in which the company holds rights (recorded in headings 284 and 51/53 of assets) for an amount of at least 10% of the capital, the equity or a class of shares of the company.
NAME, full address of the REGISTERED OFFICE and, for an entity governed by Belgian law, the COMPANY REGISTRATION NUMBER | Rights held | Data extracted from the most recent annual accounts | ||||||||||||||||||||||||||||||
Nature | Directly | Subs- idiaries | Annual accounts as per | Cur- | Equity | Net result | ||||||||||||||||||||||||||
Number | % | % | rency code | (+) or (-) (in units) | ||||||||||||||||||||||||||||
Galapagos Biopharma Netherlands | 31-12-2022 | EUR | 660.687 | 147.996 | ||||||||||||||||||||||||||||
Foreign company Zernike dreef 16 2333 CL Leiden Netherlands NL860020368B | | Registered shares |
| 500.000 | 100,00 | 0,00 | ||||||||||||||||||||||||||
Galapagos Biopharma Spain S.L.U | 31-12-2022 | EUR | 2.471.683 | -474.030 | ||||||||||||||||||||||||||||
Foreign company Cuatro Torres - Paseo de la Castellana 28046 Madrid Spain ESB67445429 | | Registered shares | | 3.000 | 100,00 | 0,00 | ||||||||||||||||||||||||||
Galapagos Biopharma Italy S.r.l. | ||||||||||||||||||||||||||||||||
Foreign company Via Montenapoleone 29 20121 Milan Italy IT1097290096 | | Registered shares |
| 50.000 | 100,00 | 0,00 | 31-12-2022 | EUR | 17.012 | 113.498 | ||||||||||||||||||||||
Galapagos Biopharma Germany | 31-12-2022 | EUR | 1.702.095 | 1.218.862 | ||||||||||||||||||||||||||||
Foreign company Theresienhoehe 30 80339 Munchen Germany DE326847734 | | Registered shares |
| 25.000 | 100,00 | 0,00 | ||||||||||||||||||||||||||
Galapagos Real Estate Netherlands | 31-12-2022 | EUR | 6.316.526 | -4.363.772 | ||||||||||||||||||||||||||||
Foreign company Zernike dreef 16 2333 CL Leiden Netherlands 860584859B01 | | Registered shares |
| 10.000.000 | 100,00 | 0,00 | ||||||||||||||||||||||||||
Galapagos Biopharma Denmark ApS Foreign company Sundkrogsgade , Harbour House 21 2100 Copenhagen Denmark 42447242 | | Registered shares |
| 40.000 | 100,00 | 0,00 | 31-12-2022 | DKK | 1.883.638 | 1.445.386 |
25/57
N°. | 0466.460.429 | F-cap 6.5.1 |
PARTICIPATING INTERESTS INFORMATION
PARTICIPATING INTERESTS AND OTHER RIGHTS IN OTHER COMPANIES
The following list mentions the companies in which the company holds a participating interest (recorded in headings 280 and 282 of assets), as well as the companies in which the company holds rights (recorded in headings 284 and 51/53 of assets) for an amount of at least 10% of the capital, the equity or a class of shares of the company.
NAME, full address of the REGISTERED OFFICE and, for an entity governed by Belgian law, the COMPANY REGISTRATION NUMBER | Rights held | Data extracted from the most recent annual accounts | ||||||||||||||||||||||||||||||
Nature | Directly | Subs- idiaries | Annual accounts as per | Cur- | Equity | Net result | ||||||||||||||||||||||||||
Number | % | % | rency code | (+) or (-) (in units) | ||||||||||||||||||||||||||||
Galapagos Biopharma Sweden AB | ||||||||||||||||||||||||||||||||
Foreign company Vasagatan 7 10123 Stockholm Sweden 559311454801 | | Registered shares |
| 25.000 | 100,00 | 0,00 | 31-12-2022 | SEK | 2.738.807 | 2.332.521 | ||||||||||||||||||||||
Galapagos Biopharma Finland Oy | ||||||||||||||||||||||||||||||||
Foreign company Bulevardi , 6th floor 1 00100 Helsinki Finland 32201288 | | Registered shares |
| 1 | 100,00 | 0,00 | 31-12-2022 | EUR | 72.004 | 62.181 | ||||||||||||||||||||||
Galapagos Biopharma Ireland Ltd | 31-12-2022 | EUR | 28.533 | 24.026 | ||||||||||||||||||||||||||||
Foreign company Block 3 Harcourt Centre, Harcourt Road D02A339 Dublin Ireland 3791298BH | | Registered shares | | 1 | 100,00 | 0,00 | ||||||||||||||||||||||||||
Galapagos Biopharma Norway AS | 31-12-2022 | NOK | 469.649 | 394.447 | ||||||||||||||||||||||||||||
Foreign company Munkedamsveien 59B 0270 Oslo Norway 927480654 | | Registered shares |
| 30.000 | 100,00 | 0,00 | ||||||||||||||||||||||||||
Galapagos Biopharma Austria Gmbh | ||||||||||||||||||||||||||||||||
Foreign company Schottenring 25 1010 Vienna Austria U77339907 | | Registered shares |
| 1 | 100,00 | 0,00 | 31-12-2022 | EUR | 435.343 | 352.988 | ||||||||||||||||||||||
Cellpoint BV | 31-12-2021 | EUR | -624.005 | -36.122.337 | ||||||||||||||||||||||||||||
Private company with limited liability De Limes 7 2342 Oestgeest Netherlands | | Registered shares |
| 210.375 | 100,00 | 0,00 |
26/57
N°. | 0466.460.429 | F-cap 6.5.1 |
PARTICIPATING INTERESTS INFORMATION
PARTICIPATING INTERESTS AND OTHER RIGHTS IN OTHER COMPANIES
The following list mentions the companies in which the company holds a participating interest (recorded in headings 280 and 282 of assets), as well as the companies in which the company holds rights (recorded in headings 284 and 51/53 of assets) for an amount of at least 10% of the capital, the equity or a class of shares of the company.
NAME, full address of the REGISTERED OFFICE and, for an entity governed by Belgian law, the COMPANY REGISTRATION NUMBER | Rights held | Data extracted from the most recent annual accounts | ||||||||||||||||||||||||||||
Nature | Directly | Subs- idiaries | Annual accounts as per | Cur- | Equity | Net result | ||||||||||||||||||||||||
Number | % | % | rency code | (+) or (-) (in units) | ||||||||||||||||||||||||||
27/57
N°. | 0466.460.429 | F-cap 6.5.2 |
LIST OF COMPANIES FOR WHICH THE COMPANY HAS UNLIMITED LIABILITY IN THE CAPACITY OF UNLIMITED LIABLE PARTNER OR MEMBER
The annual accounts of each company for which the company has unlimited liability, are being enclosed to and published with these annual accounts, unless the second column contains the reason why this is not the case; this mention is made by referring to the applicable code (A, B, C or D) defined below.
The annual accounts of the mentioned company:
A. | are published by the company by filing them at the National Bank of Belgium; |
B. | are actually published by the company in a different member country of the European Union, pursuant to article 16 of directive (EU) 2017/1132; |
C. | are being inserted by complete or proportional consolidation into the consolidated annual accounts of the company, drawn up, verified and published in accordance with the stipulations of the Belgian Companies and Associations Code concerning the consolidated annual accounts; |
D. | concern a limited partnership (société simple/maatschap). |
NAME, full address of the REGISTERED OFFICE, LEGAL FORM and, for an entity governed by Belgian law, the COMPANY REGISTRATION NUMBER | Potential code | |||
Galapagos BV Foreign company Zernikedreef 16 2333 Leiden Netherlands | C | |||
Galapagos Biopharma Netherlands B.V. Foreign company Zernike dreef 16 2333 CL Leiden Netherlands | C | |||
Galapagos Real Estate Netherlands B.V. Foreign company Zernike dreef 16 2333 CL Leiden Netherlands | C |
28/57
N°. | 0466.460.429 | F-cap 6.6 |
CURRENT INVESTMENTS AND ACCRUALS AND DEFERRED INCOME
Codes | Period | Preceding period | ||||||||||
CURRENT INVESTMENTS - OTHER INVESTMENTS | ||||||||||||
Shares and investments other than fixed income investments | 51 | |||||||||||
Shares - Book value increased with the uncalled amount | 8681 | |||||||||||
Shares - Uncalled amount | 8682 | |||||||||||
Precious metals and works of art | 8683 | |||||||||||
Fixed-income securities | 52 | |||||||||||
Fixed income securities issued by credit institutions | 8684 | |||||||||||
Term accounts with credit institutions | 53 | 1.593.596.193,52 | 1.282.508.402,57 | |||||||||
With a remaining term or notice | ||||||||||||
up to one month | 8686 | 55.000.000,00 | ||||||||||
between one month and one year | 8687 | 1.488.596.193,52 | 1.282.508.402,57 | |||||||||
over one year | 8688 | 50.000.000,00 | ||||||||||
Other investments not mentioned above | 8689 | 2.042.348.420,63 | 2.194.808.876,98 | |||||||||
Period | ||||||||||||
ACCRUALS AND DEFERRED INCOME | ||||||||||||
Allocation of account 490/1 of assets if the amount is significant | ||||||||||||
Deferred charges | 9.755.400,27 | |||||||||||
Accrued income | 10.236.175,45 | |||||||||||
Accrued subsidies | 474.545,27 |
29/57
N°. | 0466.460.429 | F-cap 6.7.1 |
STATEMENT OF CAPITAL AND SHAREHOLDERS’ STURCTURE
Codes | Period | Preceding period | ||||||||||
STATEMENT OF CAPITAL | ||||||||||||
Capital | ||||||||||||
Issued capital at the end of the period | 100P | XXXXXXXXXXXXXX | 354.582.005,11 | |||||||||
Issued capital at the end of the period | (100 | ) | 356.111.899,01 | |||||||||
Codes | Period | Number of shares | ||||||||||
Modifications during the period | ||||||||||||
Warranties - March 18th 2022 | 2.159.600,00 | 95.500 | ||||||||||
Warranties - June 20th 2022 | 1.459.506,60 | 80.920 | ||||||||||
Warranties - September 27th 2022 | 3.076.250,00 | 107.000 | ||||||||||
Composition of the capital Share types | ||||||||||||
Shares without nominal value | 356.111.899,01 | 65.835.511 | ||||||||||
Registered shares | 8702 | XXXXXXXXXXXXXX | 5.846 | |||||||||
Shares dematerialized | 8703 | XXXXXXXXXXXXXX | 65.829.665 | |||||||||
Codes | Uncalled amount | Called up amount, unpaid | ||||||||||
Unpaid capital | ||||||||||||
Uncalled capital | (101 | ) | XXXXXXXXXXXXXX | |||||||||
Called up capital, unpaid | 8712 | XXXXXXXXXXXXXX | ||||||||||
Shareholders that still need to pay up in full | ||||||||||||
Codes | Period | |||||||||||
Own shares | ||||||||||||
Held by the company itself | ||||||||||||
Amount of capital held | 8721 | |||||||||||
Number of shares | 8722 | |||||||||||
Held by a subsidiary | ||||||||||||
Amount of capital held | 8731 | |||||||||||
Number of shares | 8732 | |||||||||||
Commitments to issuing shares | ||||||||||||
Owing to the exercise of conversion rights | ||||||||||||
Amount of outstanding convertible loans | 8740 | |||||||||||
Amount of capital to be subscribed | 8741 | |||||||||||
Corresponding maximum number of shares to be issued | 8742 | |||||||||||
Owing to the exercise of subscription rights | ||||||||||||
Number of outstanding subscription rights | 8745 | 10.810.857 | ||||||||||
Amount of capital to be subscribed | 8746 | 58.477.176,80 | ||||||||||
Corresponding maximum number of shares to be issued | 8747 | 10.810.857 | ||||||||||
Authorised capital not issued | 8751 | 24.889.284,17 |
30/57
N°. | 0466.460.429 | F-cap 6.7.1 |
Codes | Period | |||||||
Shares issued, non-representing capital | ||||||||
Distribution | ||||||||
Number of shares | 8761 | |||||||
Number of voting rights attached thereto | 8762 | |||||||
Allocation by shareholder | ||||||||
Number of shares held by the company itself | 8771 | |||||||
Number of shares held by its subsidiaries | 8781 | |||||||
Period | ||||||||
ADDITIONAL NOTES REGARDING CONTRIBUTIONS (INCLUDING CONTRIBUTIONS IN THE FORM OF SERVICES OR KNOW-HOW) |
|
31/57
N°. | 0466.460.429 | F-cap 6.7.2 |
SHAREHOLDERS’ STRUCTURE OF THE COMPANY AT YEAR-END CLOSING DATE
As reflected in the notifications received by the company pursuant to article 7:225 of the Belgian Companies and Associations Code, article 14 fourth paragraph of the law of 2 May 2007 on the publication of major holdings and article 5 of the Royal Decree of 21 August 2008 on further rules for certain multilateral trading facilities.
NAME of the person(s) who hold rights of the company, together with the ADDRESS (of the registered office, in the case of a legal person) and the COMPANY REGISTRATION NUMBER, in the case of a company governed by Belgian law |
Rights held |
| ||||||||
Nature |
Number of voting rights | % | ||||||||
Attached to |
Not attached to | |||||||||
Gilead Therapeutics A1 Unlimited Company 70 Sir John Rogerson’s Quay, Dublin 2, Ireland | Dematerialized shares | 16.707.477 | 25,38% | |||||||
Van Herk Investments B.V. Lichtenauerlaan 30, 3062 ME Rotterdam, NL | Dematerialized shares | 4.635.672 | 7,04% | |||||||
EcoR1 Capital LLC 357 Tehema Street, Suite 3, San Francisco, CA 94103, United States of America | Dematerialized shares | 3.407.246 | 5,18% | |||||||
FMR LLC The Corporation Trust Center, 1209 Orange Street, Wilmington, New Castle County, Delaware, 19801 | Dematerialized shares | 3.884.633 | 5,93% |
Total shares 65.835.511,00
32/57
N°. | 0466.460.429 | F-cap 6.8 |
PROVISIONS FOR OTHER LIABILITIES AND CHARGES
Period | ||||
ALLOCATION OF ACCOUNT 164/5 OF LIABILITIES IF THE AMOUNT IS SIGNIFICANT | ||||
Provision for bonusses | 7.772.319,83 | |||
Tax recovery mechanism | 1.979.326,89 |
33/57
N°. | 0466.460.429 | F-cap 6.9 |
STATEMENT OF AMOUNTS PAYABLE AND ACCRUALS AND DEFERRED INCOME (LIABILITIES)
Codes | Period | |||||||
BREAKDOWN OF AMOUNTS PAYABLE WITH AN ORIGINAL TERM OF MORE THAN ONE YEAR, ACCORDING TO THEIR RESIDUAL MATURITY | ||||||||
Current portion of amounts payable after more than one year falling due within one year | ||||||||
Financial debts | 8801 | |||||||
Subordinated loans | 8811 | |||||||
Unsubordinated debentures | 8821 | |||||||
Leasing and other similar obligations | 8831 | |||||||
Credit institutions | 8841 | |||||||
Other loans | 8851 | |||||||
Trade debts | 8861 | |||||||
Suppliers | 8871 | |||||||
Bills of exchange payable | 8881 | |||||||
Advance payments on contracts in progress | 8891 | |||||||
Other amounts payable | 8901 | |||||||
Total current portion of amounts payable after more than one year falling due within one year | (42 | ) | ||||||
Amounts payable with a remaining term of more than one year, yet less than 5 years | ||||||||
Financial debts | 8802 | |||||||
Subordinated loans | 8812 | |||||||
Unsubordinated debentures | 8822 | |||||||
Leasing and other similar obligations | 8832 | |||||||
Credit institutions | 8842 | |||||||
Other loans | 8852 | |||||||
Trade debts | 8862 | |||||||
Suppliers | 8872 | |||||||
Bills of exchange payable | 8882 | |||||||
Advance payments on contracts in progress | 8892 | |||||||
Other amounts payable | 8902 | |||||||
Total amounts payable with a remaining term of more than one year, yet less than 5 years | 8912 | |||||||
Amounts payable with a remaining term of more than 5 years | ||||||||
Financial debts | 8803 | |||||||
Subordinated loans | 8813 | |||||||
Unsubordinated debentures | 8823 | |||||||
Leasing and other similar obligations | 8833 | |||||||
Credit institutions | 8843 | |||||||
Other loans | 8853 | |||||||
Trade debts | 8863 | |||||||
Suppliers | 8873 | |||||||
Bills of exchange payable | 8883 | |||||||
Advance payments on contracts in progress | 8893 | |||||||
Other amounts payable | 8903 | |||||||
Amounts payable with a remaining term of more than 5 years | 8913 |
34/57
N°. | 0466.460.429 | F-cap 6.9 |
Codes | Period | |||||||
AMOUNTS PAYABLE GUARANTEED (included in accounts 17 and 42/48 of liabilities) | ||||||||
Amounts payable guaranteed by the Belgian government agencies | ||||||||
Financial debts | 8921 | |||||||
Subordinated loans | 8931 | |||||||
Unsubordinated debentures | 8941 | |||||||
Leasing and other similar obligations | 8951 | |||||||
Credit institutions | 8961 | |||||||
Other loans | 8971 | |||||||
Trade debts | 8981 | |||||||
Suppliers | 8991 | |||||||
Bills of exchange payable | 9001 | |||||||
Advance payments on contracts in progress | 9011 | |||||||
Remuneration and social security | 9021 | |||||||
Other amounts payable | 9051 | |||||||
Total of the amounts payable guaranteed by the Belgian government agencies | 9061 | |||||||
Amounts payable guaranteed by real securities given or irrevocably promised by the company on its own assets | ||||||||
Financial debts | 8922 | |||||||
Subordinated loans | 8932 | |||||||
Unsubordinated debentures | 8942 | |||||||
Leasing and other similar obligations | 8952 | |||||||
Credit institutions | 8962 | |||||||
Other loans | 8972 | |||||||
Trade debts | 8982 | |||||||
Suppliers | 8992 | |||||||
Bills of exchange payable | 9002 | |||||||
Advance payments on contracts in progress | 9012 | |||||||
Taxes, remuneration and social security | 9022 | |||||||
Taxes | 9032 | |||||||
Remuneration and social security | 9042 | |||||||
Other amounts payable | 9052 | |||||||
Total amounts payable guaranteed by real securities given or irrevocably promised by the company on its own assets | 9062 | |||||||
Codes | Period | |||||||
TAXES, REMUNERATION AND SOCIAL SECURITY | ||||||||
Taxes (headings 450/3 and 178/9 of liabilities) | ||||||||
Outstanding tax debts | 9072 | |||||||
Accruing taxes payable | 9073 | 2.045.671,99 | ||||||
Estimated taxes payable | 450 | |||||||
Remuneration and social security (headings 454/9 and 178/9 of liabilities) | ||||||||
Amounts due to the National Social Security Office | 9076 | |||||||
Other amounts payable in respect of remuneration and social security | 9077 | 23.596.477,31 |
35/57
N°. | 0466.460.429 | F-cap 6.9 |
Period | ||||
ACCRUALS AND DEFERRED INCOME | ||||
Allocation of heading 492/3 of liabilities if the amount is significant | ||||
Accrued charges | 658.117,53 | |||
Deferred income | 1.872.434.570,78 | |||
Deferred subsidies | 401.985,89 | |||
Deferred tax credit | 2.320.609,28 |
36/57
N°. | 0466.460.429 | F-cap 6.10 |
OPERATING RESULTS
Codes | Period | Preceding period | ||||||||||
OPERATING INCOME | ||||||||||||
Net turnover | ||||||||||||
Allocation by categories of activity | ||||||||||||
Research & development | 418.495.174,45 | 504.765.766,17 | ||||||||||
Allocation by geographical market | ||||||||||||
US - United States | 355.933.790,09 | 455.996.790,43 | ||||||||||
FR - France | 1.061.116,70 | 617.822,68 | ||||||||||
DE - Germany | 0,00 | 73.370,17 | ||||||||||
LU - Luxemburg | 0,00 | 201,60 | ||||||||||
BS - Bahama’s | 32.218.165,73 | 45.945.880,60 | ||||||||||
BE - Belgium | 17.377.286,89 | 1.314.477,90 | ||||||||||
NL - The Netherlands | 497.511,84 | 132.995,59 | ||||||||||
ES - Spain | 513.166,04 | 16.779,71 | ||||||||||
GB - United Kingdom | 1.475.413,00 | 205.413,30 | ||||||||||
IE - Ireland | 437.798,23 | 48.750,00 | ||||||||||
IT - Italy | 1.246.643,07 | 413.284,19 | ||||||||||
AT - Austria | 2.471.940,10 | |||||||||||
CH - Switserland | 55.838,67 | |||||||||||
Fi - Finland | 264.843,47 | |||||||||||
SE - Sweden | 2.745.974,24 | |||||||||||
No - Norway | 2.195.686,38 | |||||||||||
Other operating income | ||||||||||||
Operating subsidies and compensatory amounts received from public authorities | 740 | 1.804.326,65 | 7.334.059,77 | |||||||||
OPERATING CHARGES | ||||||||||||
Employees for whom the company submitted a DIMONA declaration or who are recorded in the general personnel register | ||||||||||||
Total number at the closing date | 9086 | 442 | 460 | |||||||||
Average number of employees calculated in full-time equivalents | 9087 | 432,6 | 486,5 | |||||||||
Number of actual hours worked | 9088 | 720.120 | 821.185 | |||||||||
Personnel costs | ||||||||||||
Remuneration and direct social benefits | 620 | 59.050.615,07 | 51.904.175,20 | |||||||||
Employers’ contribution for social security | 621 | 12.402.667,84 | 12.065.178,06 | |||||||||
Employers’ premiums for extra statutory insurance | 622 | 2.558.185,67 | 3.157.632,49 | |||||||||
Other personnel costs | 623 | 3.760.651,67 | 3.232.932,08 | |||||||||
Retirement and survivors’ pensions | 624 |
37/57
N°. | 0466.460.429 | F-cap 6.10 |
Codes | Period | Preceding period | ||||||||||||||
Provisions for pensions and similar obligations | ||||||||||||||||
Appropriations (uses and write-backs) | (+ | )/(-) | 635 | |||||||||||||
Depreciations | ||||||||||||||||
On stock and contracts in progress | ||||||||||||||||
Recorded | 9110 | 1.239.142,18 | ||||||||||||||
Written back | 9111 | |||||||||||||||
On trade debtors | ||||||||||||||||
Recorded | 9112 | 7.918,89 | ||||||||||||||
Written back | 9113 | |||||||||||||||
Provisions for liabilities and charges | ||||||||||||||||
Appropriations | 9115 | 866.213,88 | ||||||||||||||
Uses and write-backs | 9116 | 2.325.058,70 | ||||||||||||||
Other operating charges | ||||||||||||||||
Taxes related to operation | 640 | 4.041.672,91 | 6.001.666,49 | |||||||||||||
Other | 641/8 | 98.107.447,13 | 114.702.066,14 | |||||||||||||
Hired temporary staff and personnel placed at the company’s disposal | ||||||||||||||||
Total number at the closing date | 9096 | |||||||||||||||
Average number calculated in full-time equivalents | 9097 | 6,5 | 1,5 | |||||||||||||
Number of actual hours worked | 9098 | 3.238 | 3.181 | |||||||||||||
Costs to the company | 617 | 84.786,53 | 77.814,29 |
38/57
N°. | 0466.460.429 | F-cap 6.11 |
FINANCIAL RESULTS
Codes | Period | Preceding period | ||||||||||
RECURRING FINANCIAL INCOME | ||||||||||||
Other financial income | ||||||||||||
Subsidies paid by public authorities, added to the profit and loss account | ||||||||||||
Capital subsidies | 9125 | |||||||||||
Interest subsidies | 9126 | |||||||||||
Allocation of other financial income | ||||||||||||
Exchange differences realized | 754 | 13.265.513,23 | ||||||||||
Other | ||||||||||||
Realized exchange gains | 3.492.091,49 | |||||||||||
Other financial gains | 31.623,18 | 2.226.830,77 | ||||||||||
Unrealized exchange gains | 89.296.991,42 | 76.997.360,15 | ||||||||||
RECURRING FINANCIAL CHARGES | ||||||||||||
Depreciation of loan issue expenses | 6501 | |||||||||||
Capitalised interests | 6502 | 2.197.496,34 | ||||||||||
Depreciations on current assets | ||||||||||||
Recorded | 6510 | 6.403.525,27 | ||||||||||
Written back | 6511 | |||||||||||
Other financial charges | ||||||||||||
Amount of the discount borne by the company, as a result of negotiating amounts receivable | 653 | 125,20 | ||||||||||
Provisions of a financial nature | ||||||||||||
Appropriations | 6560 | |||||||||||
Uses and write-backs | 6561 | |||||||||||
Allocation of other financial costs | ||||||||||||
Exchange differences realized | 654 | 9.927.653,76 | ||||||||||
Results from the conversion of foreign currencies | 655 | |||||||||||
Other | ||||||||||||
Unrealized exchange losses | 37.714.314,79 | 6.519.022,90 | ||||||||||
Bank charges | 615.691,71 | 680.918,94 | ||||||||||
Payment differences | 1.703,25 | 890,73 | ||||||||||
Other financial charges | 1.619.152,85 | 11.888,71 |
39/57
N°. | 0466.460.429 | F-cap 6.12 |
INCOME AND CHARGES OF EXCEPTIONAL SIZE OR FREQUENCY
Codes | Period | Preceding period | ||||||||||||
NON-RECURRING INCOME | 76 | 19.000,00 | 33.471.012,00 | |||||||||||
Non-recurring operating income | (76A | ) | 19.000,00 | |||||||||||
Write-back of depreciation and of amounts written off intangible and tangible fixed assets | 760 | |||||||||||||
Write-back of provisions for extraordinary operating liabilities and charges | 7620 | |||||||||||||
Capital profits on disposal of intangible and tangible fixed assets | 7630 | 19.000,00 | ||||||||||||
Other non-recurring operating income | 764/8 | |||||||||||||
Non-recurring financial income | (76B | ) | 0,00 | 33.471.012,00 | ||||||||||
Write-back of amounts written down financial fixed assets | 761 | |||||||||||||
Write-back of provisions for extraordinary financial liabilities and charges | 7621 | |||||||||||||
Capital profits on disposal of financial fixed assets | 7631 | 33.471.012,00 | ||||||||||||
Other non-recurring financial income | 769 | |||||||||||||
NON-RECURRING CHARGES | 66 | 36.854.421,48 | 16.398.135,09 | |||||||||||
Non-recurring operating charges | (66A | ) | 36.854.421,48 | 4.067.993,43 | ||||||||||
Non-recurring depreciation of and amounts written off formation expenses, intangible and tangible fixed assets | 660 | 35.566.301,65 | 634.646,46 | |||||||||||
Provisions for extraordinary operating liabilities and charges: appropriations (uses) | (+)/(-) | 6620 | ||||||||||||
Capital losses on disposal of intangible and tangible fixed assets | 6630 | 288.119,83 | 3.433.346,97 | |||||||||||
Other non-recurring operating charges | 664/7 | 1.000.000,00 | ||||||||||||
Non-recurring operating charges carried to assets as restructuring costs | (-) | 6690 | ||||||||||||
Non-recurring financial charges | (66B | ) | 0,00 | 12.330.141,66 | ||||||||||
Amounts written off financial fixed assets | 661 | 12.330.141,66 | ||||||||||||
Provisions for extraordinary financial liabilities and charges - appropriations (uses) | (+)/(-) | 6621 | ||||||||||||
Capital losses on disposal of financial fixed assets | 6631 | |||||||||||||
Other non-recurring financial charges | 668 | |||||||||||||
Non-recurring financial charges carried to assets as restructuring costs | (-) | 6691 |
40/57
N°. | 0466.460.429 | F-cap 6.13 |
TAXES
Codes | Period | |||||||||||
INCOME TAXES | ||||||||||||
Income taxes on the result of the period | 9134 | 177.909,74 | ||||||||||
Income taxes paid and withholding taxes due or paid | 9135 | 162.088,87 | ||||||||||
Excess of income tax prepayments and withholding taxes paid recorded under assets | 9136 | 162.088,87 | ||||||||||
Estimated additional taxes | 9137 | 177.909,74 | ||||||||||
Income taxes on the result of prior periods | 9138 | 18.886,82 | ||||||||||
Additional income taxes due or paid | 9139 | 18.886,82 | ||||||||||
Additional income taxes estimated or provided for | 9140 | |||||||||||
Major reasons for the differences between pre-tax profit, as it results from the annual accounts, and estimated taxable profit | ||||||||||||
Non-deductible expenses | 5.365.343,54 | |||||||||||
Tax credit | -17.346.703,58 | |||||||||||
Excess depreciations | -59.904.601,05 | |||||||||||
Exemption regional contributions | -1.804.326,65 | |||||||||||
Period | ||||||||||||
Influence of non-recurring results on income taxes on the result of the period | ||||||||||||
Codes | Period | |||||||||||
Sources of deferred taxes | ||||||||||||
Deferred taxes representing assets | 9141 | 1.761.738.121,76 | ||||||||||
Accumulated tax losses deductible from future taxable profits | 9142 | 771.545.855,69 | ||||||||||
Other deferred taxes representing assets | ||||||||||||
Investment deduction | 966.347,93 | |||||||||||
Deduction for innovation income | 346.203.444,31 | |||||||||||
Excess depreciations | 624.333.425,30 | |||||||||||
DBI | 18.689.048,54 | |||||||||||
Deferred taxes representing liabilities | 9144 | |||||||||||
Allocation of deferred taxes representing liabilities | ||||||||||||
Codes | Period | Preceding period | ||||||||||
VALUE-ADDED TAXES AND TAXES BORNE BY THIRD PARTIES | ||||||||||||
Value-added taxes charged | ||||||||||||
To the company (deductible) | 9145 | 29.346.606,12 | 22.259.517,92 | |||||||||
By the company | 9146 | 11.975.601,66 | 4.652.824,78 | |||||||||
Amounts withheld on behalf of third party by way of | ||||||||||||
Payroll withholding taxes | 9147 | 29.561.849,07 | 27.024.905,18 | |||||||||
Withholding taxes on investment income | 9148 |
41/57
N°. | 0466.460.429 | F-cap 6.14 |
RIGHTS AND COMMITMENTS NOT REFLECTED IN THE BALANCE SHEET
Codes | Period | |||||||
PERSONAL GUARANTEES PROVIDED OR IRREVOCABLY PROMISED BY THE COMPANY AS SECURITY FOR DEBTS AND COMMITMENTS OF THIRD PARTIES | 9149 | 4.066.328,05 | ||||||
|
| |||||||
Of which | ||||||||
Bills of exchange in circulation endorsed by the company | 9150 | |||||||
Bills of exchange in circulation drawn or guaranteed by the company | 9151 | |||||||
Maximum amount for which other debts or commitments of third parties are guaranteed by the company | 9153 | 4.066.328,05 | ||||||
REAL GUARANTEES | ||||||||
Real guarantees provided or irrevocably promised by the company on its own assets as security of debts and commitments of the company | ||||||||
Mortgages | ||||||||
Book value of the immovable properties mortgaged | 91611 | |||||||
Amount of registration | 91621 | |||||||
For irrevocable mortgage mandates, the amount for which the agent can take registration | 91631 | |||||||
Pledging of goodwill | ||||||||
Maximum amount up to which the debt is secured and which is the subject of registration | 91711 | |||||||
For irrevocable mandates to pledge goodwill, the amount for which the agent can take the inscription | 91721 | |||||||
Pledging of other assets or irrevocable mandates to pledge other assets | ||||||||
Book value of the immovable properties mortgaged | 91811 | |||||||
Maximum amount up to which the debt is secured | 91821 | |||||||
Guarantees provided or irrevocably promised on future assets | ||||||||
Amount of assets in question | 91911 | |||||||
Maximum amount up to which the debt is secured | 91921 | |||||||
Vendor’s privilege | ||||||||
Book value of sold goods | 92011 | |||||||
Amount of the unpaid price | 92021 |
42/57
N°. | 0466.460.429 | F-cap 6.14 |
Codes | Period | |||||||
Real guarantees provided or irrevocably promised by the company on its own assets as security of debts and commitments of third parties | ||||||||
Mortgages | ||||||||
Book value of the immovable properties mortgaged | 91612 | |||||||
Amount of registration | 91622 | |||||||
For irrevocable mortgage mandates, the amount for which the agent can take registration | 91632 | |||||||
Pledging of goodwill | ||||||||
Maximum amount up to which the debt is secured and which is the subject of registration | 91712 | |||||||
For irrevocable mandates to pledge goodwill, the amount for which the agent can take the inscription | 91722 | |||||||
Pledging of other assets or irrevocable mandates to pledge other assets | ||||||||
Book value of the immovable properties mortgaged | 91812 | |||||||
Maximum amount up to which the debt is secured | 91822 | |||||||
Guarantees provided or irrevocably promised on future assets | ||||||||
Amount of assets in question | 91912 | |||||||
Maximum amount up to which the debt is secured | 91922 | |||||||
Vendor’s privilege | ||||||||
Book value of sold goods | 92012 | |||||||
Amount of the unpaid price | 92022 | |||||||
Codes | Period | |||||||
GOODS AND VALUES, NOT REFLECTED IN THE BALANCE SHEET, HELD BY THIRD PARTIES IN THEIR OWN NAME BUT FOR THE BENEFIT AND AT THE RISK OF THE COMPANY | ||||||||
SUBSTANTIAL COMMITMENTS TO ACQUIRE FIXED ASSETS | ||||||||
Commitments to the purchase of tangible and intangible assets | 418.983,98 | |||||||
SUBSTANTIAL COMMITMENTS TO DISPOSE OF FIXED ASSETS | ||||||||
FORWARD TRANSACTIONS | ||||||||
Goods purchased (to be received) | 9213 | |||||||
Goods sold (to be delivered) | 9214 | |||||||
Currencies purchased (to be received) | 9215 | |||||||
Currencies sold (to be delivered) | 9216 | |||||||
Period | ||||||||
COMMITMENTS RELATING TO TECHNICAL GUARANTEES IN RESPECT OF SALES OR SERVICES | ||||||||
Period | ||||||||
AMOUNT, NATURE AND FORM CONCERNING LITIGATION AND OTHER IMPORTANT COMMITMENTS |
|
43/57
N°. | 0466.460.429 | F-cap 6.14 |
SETTLEMENT REGARDING THE COMPLEMENTARY RETIREMENT OR SURVIVORS’ PENSION FOR PERSONNEL AND BOARD MEMBERS
Brief description
Galapagos NV has a group insurance and guaranteed income insurance in favor of their personnel and directors. Galapagos NV carries all costs related to these insurances. The amount of the premium contribution was 2.838 K EUR in 2022.
Measures taken to cover the related charges
Code | Period | |||||||
PENSIONS FUNDED BY THE COMPANY ITSELF | ||||||||
Estimated amount of the commitments resulting from past services | 9220 | |||||||
Methods of estimation | ||||||||
Galapagos NV has a group insurance and guaranteed income insurance in favor of their personnel and directors. Galapagos NV carries all costs related to these insurances. The amount of the premium contribution was 2.838 K EUR in 2022. | ||||||||
Period | ||||||||
NATURE AND FINANCIAL IMPACT OF SIGNIFICANT EVENTS AFTER THE CLOSING DATE not reflected in the balance sheet or income statement | ||||||||
Period | ||||||||
COMMITMENTS TO PURCHASE OR SALE AVAILABLE TO THE COMPANY AS ISSUER OF OPTIONS FOR SALE OR PURCHASE | ||||||||
Period | ||||||||
NATURE, COMMERCIAL OBJECTIVE AND FINANCIAL CONSEQUENCES OF TRANSACTIONS NOT REFLECTED IN THE BALANCE SHEET | ||||||||
If the risks and benefits resulting from such transactions are of any meaning and if publishing such risks and benefits is necessary to appreciate the financial situation of the company | ||||||||
Period | ||||||||
OTHER RIGHTS AND COMMITMENTS NOT REFLECTED IN THE BALANCE SHEET (including those that cannot be calculated) |
44/57
N°. | 0466.460.429 | F-cap 6.15 |
RELATIONSHIPS WITH AFFILIATED COMPANIES, ASSOCIATED COMPANIES AND OTHER COMPANIES LINKED BY PARTICIPATING INTERESTS
Codes | Period | Preceding period | ||||||||||
AFFILIATED COMPANIES | ||||||||||||
Financial fixed assets | (280/1 | ) | 247.851.398,60 | 41.892.808,95 | ||||||||
Participating interests | (280 | ) | 154.642.557,95 | 41.892.808,95 | ||||||||
Subordinated amounts receivable | 9271 | 93.208.840,65 | ||||||||||
Other amounts receivable | 9281 | |||||||||||
Amounts receivable | 9291 | 64.503.785,72 | 97.835.332,02 | |||||||||
Over one year | 9301 | |||||||||||
Within one year | 9311 | 64.503.785,72 | 97.835.332,02 | |||||||||
Current investments | 9321 | |||||||||||
Shares | 9331 | |||||||||||
Amounts receivable | 9341 | |||||||||||
Amounts payable | 9351 | 230.595.113,48 | 170.851.849,85 | |||||||||
Over one year | 9361 | |||||||||||
Within one year | 9371 | 230.595.113,48 | 170.851.849,85 | |||||||||
Personal and real guarantees | ||||||||||||
Provided or irrevocably promised by the company as security for debts or commitments of affiliated companies | 9381 | 1.950.736,87 | 62.085.180,81 | |||||||||
Provided or irrevocably promised by affiliated companies as security for debts or commitments of the company | 9391 | |||||||||||
Other significant financial commitments | 9401 | |||||||||||
Financial results | ||||||||||||
Income from financial fixed assets | 9421 | 10.500.000,00 | 582,94 | |||||||||
Income from current assets | 9431 | |||||||||||
Other financial income | 9441 | 3.591.036,12 | 161.599,65 | |||||||||
Debt charges | 9461 | 0,00 | ||||||||||
Other financial charges | 9471 | |||||||||||
Disposal of fixed assets | ||||||||||||
Capital profits realised | 9481 | |||||||||||
Capital losses realised | 9491 |
45/57
N°. | 0466.460.429 | F-cap 6.15 |
RELATIONSHIPS WITH AFFILIATED COMPANIES, ASSOCIATED COMPANIES AND OTHER COMPANIES LINKED BY PARTICIPATING INTERESTS
Codes | Period | Preceding period | ||||||||||
ASSOCIATED COMPANIES | ||||||||||||
Financial fixed assets | 9253 | |||||||||||
Participating interests | 9263 | |||||||||||
Subordinated amounts receivable | 9273 | |||||||||||
Other amounts receivable | 9283 | |||||||||||
Amounts receivable | 9293 | |||||||||||
Over one year | 9303 | |||||||||||
Within one year | 9313 | |||||||||||
Amounts payable | 9353 | |||||||||||
Over one year | 9363 | |||||||||||
Within one year | 9373 | |||||||||||
Personal and real guarantees | ||||||||||||
Provided or irrevocably promised by the company as security for debts or commitments of affiliated companies | 9383 | |||||||||||
Provided or irrevocably promised by affiliated companies as security for debts or commitments of the company | 9393 | |||||||||||
Other significant financial commitments | 9403 | |||||||||||
COMPANIES LINKED BY PARTICIPATING INTERESTS | ||||||||||||
Financial fixed assets | 9252 | 1,00 | 1,00 | |||||||||
Participating interests | 9262 | 1,00 | 1,00 | |||||||||
Subordinated amounts receivable | 9272 | |||||||||||
Other amounts receivable | 9282 | |||||||||||
Amounts receivable | 9292 | |||||||||||
Over one year | 9302 | |||||||||||
Within one year | 9312 | |||||||||||
Amounts payable | 9352 | |||||||||||
Over one year | 9362 | |||||||||||
Within one year | 9372 |
46/57
N°. | 0466.460.429 | F-cap 6.15 |
RELATIONSHIPS WITH AFFILIATED COMPANIES, ASSOCIATED COMPANIES AND OTHER COMPANIES LINKED BY PARTICIPATING INTERESTS
Period | ||||
TRANSACTIONS WITH AFFILIATED PARTIES BEYOND NORMAL MARKET CONDITIONS | ||||
Mention of these transactions if they are significant, including the amount of the transactions, the nature of the link, and all information about the transactions that should be necessary to get a better understanding of the financial situation of the company | ||||
Due to the absence of legal criteria that allow transactions with affiliated parties beyond normal market conditions to be enumerated, no transactions were included in F-cap 6.15. |
47/57
N°. | 0466.460.429 | F-cap 6.16 |
FINANCIAL RELATIONSHIPS WITH
Codes | Period | |||||||
DIRECTORS AND MANAGERS, INDIVIDUALS OR LEGAL PERSONS WHO CONTROL THE COMPANY DIRECTLY OR INDIRECTLY WITHOUT BEING ASSOCIATED THEREWITH, OR OTHER COMPANIES CONTROLLED DIRECTLY OR INDIRECTLY BY THESE PERSONS | ||||||||
Amounts receivable from these persons | 9500 | |||||||
Principal conditions regarding amounts receivable, rate of interest, duration, any amounts repaid, cancelled or written off | ||||||||
Guarantees provided in their favour | 9501 | |||||||
Other significant commitments undertaken in their favour | 9502 | |||||||
Amount of direct and indirect remunerations and pensions, reflected in the income statement, as long as this disclosure does not concern exclusively or mainly, the situation of a single identifiable person | ||||||||
To directors and managers | 9503 | 13.845.009,67 | ||||||
To former directors and former managers | 9504 | |||||||
Codes | Period | |||||||
THE AUDITOR(S) AND THE PERSONS WHOM HE (THEY) IS (ARE) COLLABORATING WITH | ||||||||
Auditors’ fees | 9505 | 1.058.188,04 | ||||||
Fees for exceptional services or special assignments executed within the company by the auditor | ||||||||
Other audit assignments | 95061 | 26.884,74 | ||||||
Tax consultancy assignments | 95062 | |||||||
Other assignments beyond the audit | 95063 | 429.471,89 | ||||||
Fees for exceptional services or special assignments executed within the company by people the auditor(s) is (are collaborating with | ||||||||
Other audit assignments | 95081 | |||||||
Tax consultancy assignments | 95082 | |||||||
Other assignments beyond the audit | 95083 |
Mentions related to article 3:64, § 2 and § 4 of the Belgian Companies and Associations Code
48/57
N°. | 0466.460.429 | F-cap 6.18.1 |
DECLARATION WITH REGARD TO THE CONSOLIDATED ANNUAL ACCOUNTS
INFORMATION TO DISCLOSE BY EACH COMPANY GOVERNED BY THE BELGIAN COMPANIES AND ASSOCIATIONS CODE ON THE CONSOLIDATED ANNUAL ACCOUNTS
The company has prepared and published consolidated annual accounts and a consolidated annual report*
Name, full address of the registered office and, if it concerns companies under Belgian law, the company registration number of the parent company(ies) and the indication if this (these) parent company(ies) prepares (prepare) and publishes (publish) consolidated annual accounts, in which the annual accounts are included by means of consolidation**:
If the parent company(ies) is (are) (a) company(ies) governed by foreign law, the location where the abovementioned annual accounts are available**:
* | Strike out what does not apply. |
** | Where the annual accounts of the company are consolidated at different levels, the information should be given, on the one hand at the highest and on the other at the lowest level of companies of which the company is a subsidiary and for which consolidated accounts are prepared and published. |
49/57
N°. | 0466.460.429 | F-cap 6.18.2 |
FINANCIAL RELATIONSHIPS OF THE GROUP THE COMPANY IS IN CHARGE OF IN BELGIUM WITH THE AUDITOR(S) AND THE PERSONS WITH WHOM HE (THEY) IS (ARE) LINKED
Codes | Period | |||||||
Mentions related to article 3:65, § 4 and § 5 of the Belgian Companies and Associations Code | ||||||||
Fees to auditors according to the mandate at the group level led by the company publishing the information | 9507 | 1.127.098,04 | ||||||
Fees for exceptional services or special missions executed by the auditor(s) at this group | ||||||||
Other audit assignments | 95071 | 26.884,74 | ||||||
Tax consultancy assignments | 95072 | |||||||
Other assignments beyond the audit | 95073 | |||||||
Fees to people auditors are linked to according to the mandate at the group level led by the company publishing the information | 9509 | |||||||
Fees for exceptional services or special assignments executed at this group by people the auditor(s) is (are) linked to | ||||||||
Other audit assignments | 95091 | |||||||
Tax consultancy assignments | 95092 | |||||||
Other assignments beyond the audit | 95093 | 429.471,89 |
Mentions related to article 3:64, § 2 and § 4 of the Belgian Companies and Associations Code
50/57
N°. | 0466.460.429 | F-cap 6.19 |
VALUATION RULES
The valuation rules were prepared in accordance with the provisions of Chapter II of the Royal Decree of January 30, 2001 related to corporate financial statements and are valid for evaluating all assets, receivables, payables and obligations of the company.
Any changes will be submitted in advance to the Board of Directors for approval.
The current rules have been established and the evaluation rules are being carried in view of the continuation of the company.
Summary of Valuation Rules:
1. Fixed assets
(a) Intangible assets
The company invests in research and development projects. Research and development expenses are, as of fiscal year 2010, recorded on the assets only to the extent that their cost does not exceed a prudent estimate of their value in use or their future return for the company and amortized over a 3-year period through fiscal year 2015. As from fiscal year 2016 research and development costs that do not qualify as part of a development phase are recorded on the assets and fully amortized in the same fiscal year (according to CBN Opinions 2016/16 and 2016/27).
Research and development in progress acquired through licensing agreements, business combinations, collaboration agreements or separate acquisitions are recognized as intangible assets if they are separately identifiable, controlled by us and can generate economic benefit. Since there is a consideration that for separately acquired research and development assets the probability criterion is met, upfront and success payments to third parties for products or drug candidates for which approval has not yet been received have been recognized as intangible assets. We consider these intangible fixed assets not yet available for use until the underlying asset is approved and commercially launched.
As from approval for commercialization of the underlying asset, depreciation is recorded and the asset will be depreciated over its useful life.
Licenses, patents and know-how are amortized on a straight-line basis over the useful life (usually between 5 and 20 years). Other intangible assets, including acquired intellectual property, are recorded at acquisition cost. These assets are depreciated on a straight-line basis over their estimated useful lives as soon as they are ready for their intended use. They are included in the assets to the extent that their net book value does not exceed a prudent estimate of their value in use or their future returns for the company.
(b) Tangible fixed assets
Property, plant and equipment are recorded at cost. Depreciation is on a straight-line basis, taking into account the economic life of the assets.
• | Lab material: 5-10 years |
• | IT hardware and software: 3-5 years |
• | Furniture and rolling stock: 5-10 years |
3. Trade receivables
Trade receivables are recorded at face value. Foreign currency receivables are translated at the exchange rate valid at the balance sheet date. Exchange differences are recognized in the income statement.
When collection becomes doubtful, a provision is made for doubtful debtors.
4. Stocks
Raw materials, auxiliary materials and trade goods are valued at acquisition cost.
Work in progress and finished goods are valued at cost.
Cost includes, in addition to direct production and material costs, a proportionate share of depreciation and amortization of assets that were used in the production process used.
Inventories are valued using the FIFO method. If the acquisition cost or cost exceeds the net realizable value, valuation at the lower net realizable value is applied. Net realizable value is equal to the estimated normal sales price, less estimated completion costs and estimated costs required to make the sale.
5. Cash investments and liquid assets
Deposits with financial institutions are valued at nominal value. Securities are valued at acquisition cost.
Additional costs are immediately charged to earnings. Write-downs are recorded if the realization value at the balance sheet date is less than the amount previously recorded.
Foreign currency balances are translated at the exchange rate valid at the balance sheet date. Exchange differences are recorded in the income statement.
6. Provisions for other risks and costs.
This included this year’s provisions for restricted stock units following the 2018/16 CBN opinion and this reasoning was upheld for the deferred management bonus.
7. Revenue
Revenue to date consists primarily of success payments, license fees, and prepayments obtained from collaboration agreements. The Company also generates revenues from various research and development incentives and grants.
Cooperation agreements with the Company’s commercial partners for activities related to research and development generally include non-refundable prepayments received; success payments, whose receipt depends on the achievement of certain clinical, regulatory or commercial milestones; license fees and royalties on selling.
In case of revenue recognition staggered over time, the unrecognized portion is recorded as revenue carried forward.
51/57
N°. | 0466.460.429 | F-cap 6.19 |
VALUATION RULES
The revenue recognition policy can be summarized as follows:
(a) Prepayments received
Non-refundable prepayments received in connection with cooperative research agreements and development are spread and recognized over the relevant and desired period of the company’s performance commitment. Payments and company involvement are contractually defined by phase. At the outset, Management makes a estimate of the duration of the company’s involvement, as well as the costs related to the project. Prepayments are recognized over the expected period of engagement, either on a straight-line basis or based on costs incurred in the framework of the project if these costs can be reliably estimated. Periodically, the Company reviews the estimated time and cost for the project and adjusts the period over which revenue is spread.
(b) Success payments
A success payment is included in the transaction price only when there is a substantial likelihood that a material reversal of cumulative recognized revenue will not occur.
Success payments that are not irrevocable, substantial or proportionate, are recognized as revenue to be carried forward. Revenue from these activities can vary greatly from period to period due to the timing of the success payment.
(c) Licenses
Revenues arising from licenses limited in time are spread over the period covered by the license, which increases the obligation of the license reflects over that term, to update the content and ensure continuous updating.
Proceeds from perpetual licenses are recognized immediately upon sale to the extent that there are no further obligations.
(d) Royalty agreements
Royalty income is recognized when the Company can estimate the amount with reasonable certainty and a reasonable assurance of collectability exists. As a result, the company is generally going to recognize royalties in the period that the licensee reported the royalties to the company through royalty reports, i.e., the royalty income is normally recognized only retrospectively, after the period in which sales by the licensee have occurred. Under this accounting rule, revenues arising from royalties included in the reporting of the company are not based on an estimate by the company but are typically reported in the same period as the obtained payment from the licensee.
(e) Grants and R&D support measures.
Because the company participates extensively in research and development activities, the company also benefits from multiple subsidies and R&D support measures from certain government agencies. These subsidies and R&D support measures are generally used to partially reimburse approved research and development costs. They are therefore credited to the earnings, under other income (excluding tax credit for research and development costs), when the relevant expenditures have been made and reasonable certainty exists about the subsidies (to be) received and R&D support measures.
8. Continuity
To date, we have incurred significant operating losses, which is reflected in the balance sheet. However, we believe that our existing short-term financial investments, cash and cash equivalents at December 31, 2022 will enable us to fund our operating costs and capital expenditures for at least the next 12 months. The Board of Directors is also of the opinion that additional funding—if needed—can be obtained. Taking this into account, as well as the potential developments in our drug discovery and development activities, the Board of Directors believes that they can present the financial statements on a going concern basis. Although our short-term financial investments, cash and cash equivalents are sufficiently high for at least the next 12 months, the Board of Directors points out that if R&D activities go well, we will could seek additional funding to support the ongoing development of our products or to support other business opportunities.
52/57
N°. | 0466.460.429 | F-cap 6.20 |
OTHER INFORMATION TO DISCLOSE
A comfort letter was provided to Galapagos Real Estate Belgium B.V.
53/57
N°. | 0466.460.429 | F-cap 10 |
SOCIAL BALANCE SHEET
Numbers of the joint industrial committees competent for the company: | 207 |
STATEMENT OF THE PERSONS EMPLOYED
EMPLOYEES FOR WHOM THE COMPANY SUBMITTED A DIMONA DECLARATION OR WHO ARE RECORDED IN THE GENERAL PERSONNEL REGISTER
During the period | Codes | Total | 1. Men | 2. Women | ||||||||||||
Average number of employees | ||||||||||||||||
Full-time | 1001 | 372,9 | 165,2 | 207,7 | ||||||||||||
Part-time | 1002 | 73,3 | 14,5 | 58,8 | ||||||||||||
Total in full-time equivalents (FTE) | 1003 | 432,6 | 176,6 | 256,0 | ||||||||||||
Number of actual hours worked | ||||||||||||||||
Full-time | 1011 | 620.760 | 278.424 | 342.336 | ||||||||||||
Part-time | 1012 | 99.360 | 19.142 | 80.218 | ||||||||||||
Total | 1013 | 720.120 | 297.566 | 422.554 | ||||||||||||
Personnel costs | ||||||||||||||||
Full-time | 1021 | 68.009.426,21 | 34.535.868,72 | 33.473.557,49 | ||||||||||||
Part-time | 1022 | 9.762.694,04 | 2.186.004,77 | 7.576.689,27 | ||||||||||||
Total | 1023 | 77.772.120,25 | 36.721.873,49 | 41.050.246,76 | ||||||||||||
Benefits in addition to wages | 1033 | 567.933,27 | 232.741,71 | 335.191,56 | ||||||||||||
During the preceding period | Codes | P. Total | 1P. Men | 2P. Women | ||||||||||||
Average number of employees in FTE | 1003 | 486,5 | 200,9 | 285,6 | ||||||||||||
Number of actual hours worked | 1013 | 821.185 | 346.335 | 474.850 | ||||||||||||
Personnel costs | 1023 | 70.359.917,83 | 29.055.102,76 | 41.304.815,07 | ||||||||||||
Benefits in addition to wages | 1033 | 644.893,29 | 270.276,12 | 374.617,17 |
54/57
N°. | 0466.460.429 | F-cap 10 |
EMPLOYEES FOR WHOM THE COMPANY SUBMITTED A DIMONA DECLARATION OR WHO ARE RECORDED IN THE GENERAL PERSONNEL REGISTER (continuation)
At the closing date of the period | Codes | 1. Full-time | 2. Part-time | 3. Total in full-time equivalents | ||||||||||||
Number of employees | 105 | 367 | 75 | 428,1 | ||||||||||||
By nature of the employment contract | ||||||||||||||||
Contract for an indefinite period | 110 | 367 | 75 | 428,1 | ||||||||||||
Contract for a definite period | 111 | |||||||||||||||
Contract for the execution of a specifically assigned work | 112 | |||||||||||||||
Replacement contract | 113 | |||||||||||||||
According to gender and study level | ||||||||||||||||
Men | 120 | 162 | 15 | 173,8 | ||||||||||||
primary education | 1200 | 27 | 27,0 | |||||||||||||
secondary education | 1201 | 9 | 1 | 9,8 | ||||||||||||
higher non-university education | 1202 | 21 | 5 | 24,8 | ||||||||||||
university education | 1203 | 105 | 9 | 112,2 | ||||||||||||
Women | 121 | 205 | 60 | 254,3 | ||||||||||||
primary education | 1210 | 19 | 3 | 21,4 | ||||||||||||
secondary education | 1211 | 5 | 2 | 6,3 | ||||||||||||
higher non-university education | 1212 | 46 | 16 | 58,8 | ||||||||||||
university education | 1213 | 135 | 39 | 167,8 | ||||||||||||
By professional category | ||||||||||||||||
Management staff | 130 | |||||||||||||||
Salaried employees | 134 | 367 | 75 | 428,1 | ||||||||||||
Hourly employees | 132 | |||||||||||||||
Other | 133 |
HIRED TEMPORARY STAFF AND PERSONNEL PLACED AT THE DISPOSAL OF THE COMPANY
During the period | Codes | 1. Hired temporary staff | 2. Hired temporary staff and personnel placed at the company’s disposal | |||||||
Average number of persons employed | 150 | 6,5 | ||||||||
Number of actual hours worked | 151 | 3.238 | ||||||||
Costs to the company | 152 | 84.786,53 |
55/57
N°. | 0466.460.429 | F-cap 10 |
LIST OF PERSONNEL MOVEMENTS DURING THE PERIOD
Codes | 1. Full-time | 2. Part-time | 3. Total in full-time equivalents | |||||||||||||
ENTRIES | ||||||||||||||||
Number of employees for whom the company submitted a DIMONA declaration or who have been recorded in the general personnel register during the period | 205 | 47 | 2 | 48,6 | ||||||||||||
By nature of the employment contract | ||||||||||||||||
Contract for an indefinite period | 210 | 47 | 2 | 48,6 | ||||||||||||
Contract for a definite period | 211 | |||||||||||||||
Contract for the execution of a specifically assigned work | 212 | |||||||||||||||
Replacement contract | 213 | |||||||||||||||
Codes | 1. Full-time | 2. Part-time | 3. Total in full-time equivalents | |||||||||||||
DEPARTURES | ||||||||||||||||
Number of employees whose contract-termination date has been included in the DIMONA declaration or in the general personnel register during the period | 305 | 62 | 5 | 66,1 | ||||||||||||
By nature of the employment contract | ||||||||||||||||
Contract for an indefinite period | 310 | 62 | 5 | 66,1 | ||||||||||||
Contract for a definite period | 311 | |||||||||||||||
Contract for the execution of a specifically assigned work | 312 | |||||||||||||||
Replacement contract | 313 | |||||||||||||||
By reason of termination of contract | ||||||||||||||||
Retirement | 340 | 2 | 2,0 | |||||||||||||
Unemployment with extra allowance from enterprise | 341 | |||||||||||||||
Dismissal | 342 | 8 | 1 | 8,8 | ||||||||||||
Other reason | 343 | 52 | 4 | 55,3 | ||||||||||||
Of which: the number of persons who continue to render services to the company at least halftime on a self-employment basis | 350 |
56/57
N°. | 0466.460.429 | F-cap 10 |
INFORMATION ON TRAINING PROVIDED TO EMPLOYEES DURING THE PERIOD
Codes | Men | Codes | Women | |||||||||||||
Total of initiatives of formal professional training at the expense of the employer | ||||||||||||||||
Number of employees involved | 5801 | 5811 | ||||||||||||||
Number of actual training hours | 5802 | 5812 | ||||||||||||||
Net costs for the company | 5803 | 5813 | ||||||||||||||
of which gross costs directly linked to training | 58031 | 58131 | ||||||||||||||
of which contributions paid and payments to collective funds | 58032 | 58132 | ||||||||||||||
of which grants and other financial advantages received (to deduct) | 58033 | 58133 | ||||||||||||||
Total of initiatives of less formal or informal professional training at the expense of the employer | ||||||||||||||||
Number of employees involved | 5821 | 177 | 5831 | 256 | ||||||||||||
Number of actual training hours | 5822 | 3.339 | 5832 | 6.228 | ||||||||||||
Net costs for the company | 5823 | 432.927,54 | 5833 | 964.746,92 | ||||||||||||
Total of initial initiatives of professional training at the expense of the employer | ||||||||||||||||
Number of employees involved | 5841 | 5851 | ||||||||||||||
Number of actual training hours | 5842 | 5852 | ||||||||||||||
Net costs for the company | 5843 | 5853 |
57/57